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Due to their structural similarity to the native collagenous extracellular matrix (ECM), fibrous 
scaffolds are widely studied in cell-based cartilage and bone tissue engineering research. Recent 
studies report that cell behavior is affected by scaffold fiber diameter, although findings are 
inconsistent regarding whether fibers less than or greater than 1 µm are better substrates for 
chondrogenesis and osteogenesis. Differences in other experimental parameters between studies 
likely influence the outcomes, resulting in seemingly conflicting conclusions. Therefore, we 
explored the effects of scaffold fiber diameter on human mesenchymal stem cell (MSC) 
differentiation in conjunction with other culture parameters. Poly(ε-caprolactone) (PCL) 
electrospun microfibers (3-4 µm diameter) and nanofibers (300-400 nm diameter) were 
fabricated and utilized. First, we showed that microfibrous scaffolds are superior for inducing 
chondrogenesis at high initial seeding densities (2-4x106 cells/cm3-scaffold), likely due to larger 
pore sizes within the scaffold promoting cell-cell contact as well as improved cellular infiltration. 
At lower seeding densities (1-5x105 cells/cm3-scaffold) chondrogenesis is not strongly induced 
regardless of fiber diameter, suggesting high cell seeding densities are required to assess effects 
of biomaterials on chondrogenesis. Next, enhanced chondrogenesis on microfibers was found to 
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be independent of tissue origin of MSCs, with much more robust chondrogenesis seen on 
microfibers than nanofibers for both bone marrow-derived MSCs (BMSCs) and adipose-derived 
MSCs (ADSCs), although the latter is generally less chondrogenic on either fiber diameter. 
Interestingly, under osteogenic conditions, BMSCs were not as sensitive to fiber diameter, but 
ADSCs demonstrated increased osteogenic potential on microfibers. Therefore, not only the 
lineage of differentiation, but also cell source must be taken into account when determining the 
optimal scaffold fiber diameter for cell-based skeletal tissue engineering. Lastly, we assessed the 
potential of enhancing MSC osteogenesis via sequential co-seeding with endothelial cells (ECs). 
Seeding MSCs onto scaffolds three days prior to ECs resulted in enhanced osteogenic 
differentiation in comparison to MSC monoculture, seeding ECs first, or simultaneously seeding 
both cell types. Taken together, these studies demonstrate that detailed examination of the 
interactions between different culture parameters, including scaffold architecture, seeding 
density, cell source, and differentiation lineage is essential for developing effective skeletal 
tissue engineering strategies. 
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1.0  INTRODUCTION 
1.1 BONE BIOLOGY AND DISEASE 
1.1.1 Bone development 
Bone formation occurs through two types of processes: intramembranous and endochondral 
ossification. Intramembranous ossification occurs directly by differentiation of mesenchymal 
osteoprogenitors into osteoblasts that form ossification centers. Intramembranous ossification is 
the process through which many craniofacial bones are formed. Endochondral ossification is the 
pathway that leads to formation of long bones as well as the vertebrae and occurs through a 
cartilage intermediate as described below. 
Limb development is initiated as undifferentiated mesenchymal cells from the lateral 
plate mesoderm proliferate and migrate under a layer of specialized epithelial cells known as the 
apical ectodermal ridge (AER), bulging outwards to form the limb bud.1 Eventually, the 
mesenchymal cells in the elongating limb bud slow their migration and proliferation and begin to 
aggregate. As the inter-cellular distance decreases, cell-cell contacts are formed via proteins 
including N-cadherin and neural cell adhesion molecule (N-CAM),2,3 and cells begin to 
differentiate into pre-chondrocytes. A shift in extracellular matrix (ECM) production also  
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occurs, as collagen type I produced by the undifferentiated mesenchyme is degraded and 
replaced with collagen type II and aggrecan, producing a cartilaginous matrix and resulting in 
formation of a cartilage anlage.4  
Chondrocytes in the cartilage anlagen continue to proliferate and deposit ECM, extending 
the length of the tissue. Eventually, cells in the center are triggered to exit the cell cycle and 
become hypertrophic, increasing in size and mineralizing the surrounding matrix. Hypertrophic 
chondrocytes also secrete signals inducing sprouting angiogenesis and blood vessel invasion 
from the surrounding perichondrial vessels. Osteoclasts arriving through the blood vessels then 
degrade the cartilage ECM, aiding further vessel invasion towards the center of the tissue. At the 
same time, hypertrophic chondrocytes undergo apoptosis and are replaced by bone-forming 
osteoblasts and bone marrow cells, resulting in formation of the primary ossification center. 
Osteoblasts from the perichondrium also deposit tissue on the outside edge of the cartilage, 
forming a compact bone collar around the cartilage and the primary ossification center. 
Postnatally, secondary ossification centers also form at the epiphyses of bones. The cartilage in 
between the primary and secondary ossification centers forms the ephiphyseal growth plate, 
which is eventually ossified during adolescence, often referred to as “closure of the growth 
plate”, as the primary and secondary centers meet.5,6 
1.1.2 Bone structure and composition 
The overall structure of mature bone consists of a dense cortical outer layer that surrounds the 
spongy trabecular bone that contains the bone marrow compartment. Fifty to 70% of bone is 
calcium phosphate mineral, mostly in the form of hydroxyapatite, which provides the strength of 
the tissue. Organic matrix makes up 20-40% of bone, while 5-10% is water and a small 
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percentage is lipids.7 Collagen type I is by far the most abundant protein secreted by osteoblasts, 
comprising 90% of the protein components of the bone, and provides the elasticity needed to 
withstand repeated loading.7 Osteocalcin and osteonectin are the other major components, 
comprising approximately 40-50% of the non-collagenous proteins. Biglycan and decorin, along 
with cell-binding proteins bone sialoprotein, osteopontin, fibronectin, vitronectin, and 
thrombospondin are also present in lower abundance.8 
1.1.3 Bone remodeling 
Bone is continuously remodeling throughout life in a tightly coupled process of resorption and 
deposition. As osteoclasts advance, digesting old tissue, osteoblasts follow behind, depositing 
new matrix.8 During initial bone formation, as well as during fracture repair, osteoblasts lay 
down a relatively weak and disorganized bone matrix, termed “woven” bone. This is quickly 
resorbed by osteoclasts and replaced by a more organized, stronger lamellar bone with collagen 
arranged in concentric, orthogonally oriented layers around a blood vessel, in a structure called 
the osteon. As osteoblasts mature, they become surrounded by mineralized matrix, and undergo 
terminal differentiation to become osteocytes. Osteocytes communicate with the surrounding 
cells and bone surface using dendritic cell processes that travel through an extensive canalicular 
system.9  
1.1.4 Bone defects and treatment 
Most bone fractures in healthy patients heal without intervention beyond immobilization and 
stabilization. However, approximately 5-10% of fractures suffer from delayed or non-union, and 
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other problems including trauma, surgical tumor removal, genetic disease, and joint replacement 
revision surgery result in the need for more than 1.5 million bone graft procedures to be 
performed in the US each year.10 Autologous bone grafts, typically obtained from the iliac crest, 
are the clinical gold standard and have relatively high success rates, but there is a limited amount 
of tissue that can be obtained, as well as potential donor site morbidity.11,12 Allografts from 
deceased donors can be used to circumvent availability issues, but suffer from potential immune 
rejection, disease transmission, and reduced osteoinductive capabilities due to the need to pre-
treat the tissue./sup> Osteoconductive synthetic grafts, fabricated from such materials as 
collagen, hydroxyapatite, and tricalcium phosphate, are currently used clinically, but due to non-
ideal mechanical properties are typically utilized only as a supplement to autologous or 
allogeneic bone grafts rather than as a replacement by themselves. 
1.2 CARTILAGE BIOLOGY AND DISEASE 
1.2.1 Cartilage development 
While most of the cartilage anlagen are completely replaced by bone, the cartilage tissue that is 
found at the surface of the articulating joints such as the knee and hip is permanent. The “stable” 
chondrocytes that make up the articular cartilage are derived from mesenchymal cells that arise 
near the interzone, the location where joint formation takes place. As joint development begins, 
the interzone divides into three layers: two chondrogenic layers and an intermediate layer. It is 
thought that the articular cartilage arises from the intermediate layer, while the deeper  
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chondrogenic layers become incorporated into the epiphysis as the ECM becomes reorganized 
and cavitation occurs to form the joint space, with articular cartilage lining the surface of the 
bone.14–16 
1.2.2 Cartilage structure and composition 
Mature articular cartilage is a hypocellular, avascular tissue with chondrocytes the only type of 
cells normally found within the tissue. Cartilage may contain up to 80% water by weight, while 
60-70% of the dry weight of cartilage is collagen, mostly collagen type II, and 25-35% is 
proteoglycans, mostly aggrecan.17 Articular cartilage is arranged into four zones: superficial, 
intermediate, deep, and calcified. In the superficial zone, chondrocytes have a flattened 
morphology and the collagen fibers are arranged parallel to the surface. Proteoglycan content in 
the superficial zone is also lower than in other regions. In the intermediate zone, chondrocytes 
become more spherical in shape, organizing themselves into vertical columns, and collagen 
fibers are arranged randomly. In the deep zone, collagen is oriented perpendicular to the surface 
of the joint, forming struts that cross the tidemark to integrate into the calcified cartilage zone. 
The calcified cartilage zone serves as the transition between the cartilage above and the 
subchondral bone below.17 
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1.2.3 Cartilage remodeling 
Since cartilage is avascular, chondrocytes exist under chronically hypoxic conditions. Therefore, 
in the absence of significant physiological perturbations, the metabolic activity of chondrocytes 
is low. However, chondrocytes are sensitive to both cytokines as well as mechanical loading, and 
can modify the cartilage matrix in response, although its capacity for repair is limited.17–19 
1.2.4 Osteoarthritis disease and treatment 
Conservative estimates find that nearly 14% of the United States population over the age of 25 is 
affected by osteoarthritis (OA) with over $185 billion spent in the United States on healthcare 
related to the disease in 2007.20 As the population continues to age, the prevalence of OA is 
predicted to increase.21,22 OA is caused by degeneration of the articular cartilage over time and 
can be due to a previous acute injury (post-traumatic OA), chronic altered joint loading, or both, 
as well as other yet to be ascertained factors, including genetics and aging. Under these 
conditions, chemical or mechanical stimuli shift chondrocytes towards a more catabolic 
phenotype, increasing their secretion of matrix metalloproteases and pro-inflammatory 
cytokines, and the organization of the collagen network decreases.2324 Glycosaminoglycans, a 
major component of the sulfated proteoglycans of cartilage, are also lost and tissue hydration 
decreases. The result is an overall deterioration of the cartilage, with loss of surface smoothness 
and increasing tissue loss, potentially reaching the level of the osteochondral layer. The result of 
this breakdown is pain and limited physical functioning, leading to a decreased quality of life. 
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Symptomatic management with non-steroidal anti-inflammatory drugs, cyclooxygenase-2 
inhibitors, or intra-articular corticosteroid injections are the current standard of care, while joint 
replacement surgery, or arthroplasty, is the only currently available treatment for advanced 
stages of osteoarthritis. Nearly one million hip and knee replacements are performed in the US 
annually,25 and while arthroplasty can alleviate symptoms, these implants typically only last 10-
15 years, primarily due to the failure of the tissue-implant interface, and revision surgery is often 
required — 17.5% and 8.2% of hip and knee replacements, respectively, needed revision 
between 1990 and 2002. Additionally, patients undergoing joint replacement are still typically 
unable to match the functional abilities of their healthy counterparts following the procedure.26 
1.3 TISSUE ENGINEERING 
1.3.1 Definition 
Improved methods for treating cartilage and bone defects are needed. Over the last two decades, 
tissue engineering has emerged as an attractive approach, as it eliminates the issue of donor 
tissue shortages as well as immune rejection. As defined by Langer and Vacanti, tissue 
engineering is “an interdisciplinary field of research that applies the principles of engineering 
and the life sciences towards the development of biological substitutes that restore, maintain, or 
improve tissue function.”27 More specifically, tissue engineering utilizes a combination of cells, 
scaffolds and bioactive factors in strategic combinations to direct the in vitro formation of new 
tissues or organs. 
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1.3.2 Cells in tissue engineering 
In order to eliminate the need for immunosuppression, regenerative medicine and tissue 
engineering approaches have generally focused on using autologous donor-derived cells or cells 
that will not elicit an immune response. However, terminally differentiated cells are typically 
limited in their ability to proliferate and it is therefore difficult to obtain sufficient cell number 
for regeneration of tissues. In addition, cells from tissues to be treated or replaced are likely to 
have undesirable defects that require structural repair. Because of this limited potential using 
differentiated cells, the use of stem or progenitor cells has become ubiquitous in the fields tissue 
engineering and regenerative medicine. The characteristics that define stem cells—capacity for 
self-renewal, long-term proliferation and the ability to differentiate into several different cell 
types—make them the optimal cell source for the development of new tissues and organs. 
Stem cells are typically classified into two main groups: embryonic and adult. Embryonic 
stem cells (ESCs) are derived from the inner cell mass of blastocysts in the developing embryo 
prior to implantation. These cells are pluripotent, i.e., ESCs have the ability to differentiate into 
cells comprising all three germ layers, and can be maintained in culture in an undifferentiated 
state for indefinite periods of time.28 While these characteristics render ESCs an attractive cell 
source for regeneration of tissues and organs, they suffer from several limitations. First, ESCs 
present an ethical issue since embryos are destroyed in the process of obtaining the cells; second, 
since they are obtained from allogeneic sources, there is the possibility of an immune response, 
although research suggests that this response may be weaker than with traditional organ 
transplant; third, due to their undifferentiated state, there is a possibility that ESCs can become 
tumorigenic and malignant.29 
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Adult stem cells, on the other hand, are isolated from post-natal tissues. They can also 
differentiate down multiple lineages, but are more restricted in the types of cells that they can 
become and have more limited proliferation potential in comparison to ESCs. One advantage of 
adult stem cells compared to ESCs is that they can often be obtained from the patient themselves, 
thereby obviating the issue of immune rejection. However, if the tissue that cells are desired 
from is diseased, or has limited availability of stem cells (e.g., nervous tissue), it may not be 
possible to obtain autologous cells. One type of adult stem cells that have been found to be 
particularly well-suited for bone and cartilage tissue engineering are mesenchymal stem cells 
(MSCs). These cells have been isolated from many different adult tissues including but not 
limited to bone marrow, fat, synovium, cartilage, muscle, and dental pulp. MSCs have also been 
isolated from prenatal and perinatal tissues such as the umbilical cord, umbilical cord blood, and 
placenta30 Bone marrow-derived MSCs (BMSCs) and adipose-derived MSCs (ADSCs) are the 
most commonly utilized MSCs. Both of these cell types have shown the ability to differentiate 
into cartilage, bone, and fat, making them particularly useful for regeneration of musculoskeletal 
and connective tissues. In addition to their multipotent differentiation ability, MSCs have been 
shown to be hypoimmunogenic as well as immunosuppressive, even after differentiation.31–33  
While adult stem cells are multipotent, unlike ESCs they are somewhat lineage-restricted 
and typically only differentiate readily towards a few cell types and therefore are useful for a 
limited number of tissues. Recent advances, however, have led to the ability to reprogram 
somatic cells, including those that have undergone lineage specific differentiation, into an ESC-
like state. Takahashi, et. al. showed that the retroviral mediated expression of four nuclear 
transcription factors—Oct4, Sox2, Klf4, and c-Myc—resulted in cells with expression patterns 
and differentiation capacity cells similar to ESCs. These induced pluripotent stem cells (iPS 
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cells) may allow scientists to overcome the ethical and immune rejection concerns of ESCs while 
retaining the increased proliferation and differentiation capacity that make the use of ESCs over 
typical adult stem cells desirable. Initial concerns that utilizing viruses or vectors that integrate 
into the genome may lead to the development of tumors are being addressed by using transient or 
removable vectors or by directly delivering proteins.34–39 Despite autologous cells being used,  
recent studies show that iPS cells may generate an immune response upon implantation,40 
suggesting that while these cells may have promise, significantly more research must be 
conducted prior to clinical translation. 
1.3.3 Biomaterials in tissue engineering 
In tissue engineering, biomaterials serve as the scaffolding upon which cells build tissues. The 
definition of biomaterials has recently been re-visited and is now interpreted as encompassing 
natural or synthetic materials that interact with biological systems. The use of biomaterials in 
medicine has been studied for centuries, with dental implants made from wood and contact 
lenses comprised of glass being among the first common applications of biomaterials. Because 
early implants were designed to be permanent and little was known about the mechanisms 
behind the foreign body response, initial biocompatibility studies in the 1940’s focused on 
determining which materials were the least chemically reactive. However, this changed with the 
development of applications where it was desirable for the biomaterial to interact directly with 
the host tissue as well as degrade over time. Therefore, the definition of biocompatibility has 
become focused on materials having an “appropriate host response” rather than limiting the 
response.41 Today, in addition to being biocompatible, biomaterials in tissue engineering 
applications have become increasingly sophisticated and are designed to meet several criteria.42 
  10 
First, they should provide appropriate mechanical strength to ensure that the tissue can withstand 
the normal forces it experiences and/or perform its physical functions in vivo. Second, they must 
provide a compatible surface for cell attachment and appropriate topographical information.  
Third, they should ideally be designed to degrade over a length of time that is appropriate for the 
specific application, such that the ultimate engineered tissue is able to approximate its original 
state. 
Synthetic polymers have an advantage over natural polymers as biomaterials for tissue 
engineering since they may be produced using defined processes, and have highly tunable 
mechanical and chemical properties to enhance biocompatibility. However, nature’s 
biomaterial—the extracellular matrix (ECM)—already possesses the optimal properties to 
support cellular attachment and tissue growth, often in a tissue-specific manner. This has led 
tissue engineers to study in depth the structure and composition of the native ECM as well as 
investigate the cell-material interactions with the goal of recreating this environment. 
The native ECM is a complex and dynamic network of proteins that provide both 
structural and biochemical support to the cells it surrounds. Rather than just serving as a passive 
scaffold, the ECM also provides important mechanical, topographic, and biochemical cues that 
can influence cell attachment, survival, shape, proliferation, migration, and differentiation.43 The 
most abundant protein in the ECM is collagen, which makes up approximately 30% of the total 
protein in the human body. Mature collagen is a triple-helix of three polypeptides that align and 
combine themselves to form collagen fibrils that are typically between 50 and 500 nm in 
diameter.44,45 Other fibrous proteins such as fibronectin, laminin and elastin are also present in 
significant quantities and influence the structural and mechanical properties of the tissue. In 
addition to the fibrous proteins, the ECM also contains glycoproteins as well as bound or 
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entrapped growth factors that can significantly influence the properties of the tissue. Each 
component of the ECM influences cell behavior via specific interactions, often involving ligand-
specific receptors on the cell membrane. Therefore, recapitulation of the structure of the native 
microenvironment using biomaterials with nanoscale features may provide the optimal 
biomimetic topographic structure for cells to form tissues with similar properties to the native 
tissue. 
There are two levels of interactions that must be investigated in order to develop the 
optimal tissue engineered solution for clinical use: (1) the cell-material interactions in vitro after 
initial cell seeding, and (2) the interactions of the tissue-engineered constructs with the host 
tissues following implantation. While the ultimate goal of tissue engineering research is to 
develop a construct that can be implanted and function in vivo, it is imperative to first gain a 
thorough understanding of the cell-scaffold interactions in well-defined in vitro environments. 
Tissue engineering research currently focuses on applying knowledge of the biological 
characteristics of native cellular and tissue microenvironment to the development of biomaterial-
based constructs that mimic these behaviors when combined with cells. 
1.3.4 Three-dimensional scaffolds 
Extensive studies have shown that there are clear differences in cell behavior and tissue 
formation on flat surfaces in comparison to 3D ECM scaffolds, and that these differences occur 
at the protein and sub-protein level. Furthermore, these differences are present even when the 2D 
scaffold has the same chemical and molecular composition.46,47 These findings, in combination 
with the evidence that nanoscale topography affects cell behavior, have pushed scientists to 
utilize tissue-engineering approaches that mimic the 3D sub-micron structure of the native ECM. 
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The currently available techniques for scaffold fabrication do not approach the complexity of the 
native ECM structure, nor can the environment be as closely controlled as with the 2D 
nanotopography described above. However, this may not be necessary as scaffolds in tissue 
engineering studies are designed to act primarily as a temporary structure to support cells until 
they are able to synthesize their own functional ECM. Therefore the goal in successful 
application of 3D tissue engineered scaffolds is to identify and enhance key components that will 
provide the appropriate signals to cells in order to generate a functional tissue that can be 
translated into clinical use. 
1.3.5 Electrospinning 
Electrospinning has recently become among the most commonly used method for the fabriction 
of nanofibrous biomaterials. This method involves the application of a high electric field to a 
polymer solution delivered at a constant rate through a needle. At a high enough voltage, the 
charge on the polymer overcomes the surface tension of the solution and causes emission of a 
fine polymer jet. This jet undergoes a whipping process and the fibers are further elongated as 
the solvent evaporates and fibers are deposited on a grounded collector. Both natural and 
synthetic polymer scaffolds have been successfully created using the electrospinning method. 
The ability to generate three-dimensional scaffolds with tailored architecture, mechanical 
properties and degradation characteristics, has made electrospinning a popular method in tissue 
engineering applications. Altering parameters during the electrospinning process, such as 
polymer concentration, flow rate of the solution and voltage applied, can generate fibers ranging  
  13 
from approximately 100 nanometers to several micrometers in diameter. Scaffolds with aligned 
fibers can be created by collecting fibers on a drum or mandrel rotating at high speeds, while 
randomly oriented fibers are generated on slow rotating or stationary collectors. 
Various polymers have been used in electrospinning of nanofiber scaffolds. These include 
synthetic polymers such as poly (L-lactic acid) (PLLA), poly(ε-caprolactone) (PCL), and 
polyurethane,48 as well as natural polymers such as collagen,49–52 elastin, silk fibroin, dextran,53 
and chitosan.54,55 Because the synthetic polymers typically used in electrospinning are 
hydrophobic and lack biologically active functional groups, they are often modified either 
physically or chemically following the electrospinning process to increase their hydrophilicity 
and ability to interact with cells and biomolecules. 
Plasma etching, similar to that performed on tissue-culture polystyrene, can generate 
functional carboxyl or amine groups on the surface of the fibers, which has been shown to 
enhance cell attachment and proliferation either alone,56,57 or via the coating of the functionalized 
fiber with a natural ECM protein such as collagen58 or gelatin.59 Wet chemical etching methods 
may provide more homogeneous functionalization in thicker scaffolds since plasma etching can 
only penetrate the outer surface of a thicker scaffold. This method typically involves NaOH 
hydrolysis or aminolysis of the polymer, breaking the ester bond at random points and creating a 
hydroxyl or amino group, respectively.60 One study demonstrated that esophageal epithelial cells 
seeded on aminolyzed poly(L-lactide-co-caprolactone) coated with fibronectin exhibited higher 
collagen type IV synthesis than those seeded on the unmodified polymer, suggesting that this 
method may be useful in tissue engineering studies.58,61 
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Composite scaffolds formed from co-electrospinning of different polymers have been 
utilized to control the mechanical as well as structural properties of the scaffold. Perhaps the 
biggest challenge using the electrospinning method is that the pore size is typically much smaller 
than the diameter of a typical cell, a property that makes cell and nutrient infiltration into the 
middle of the scaffold difficult. Several methods have been used to overcome this problem, 
including spinning of mixed microfiber and nanofibers scaffolds,62 as well as using water-soluble 
polymers (i.e. polyethylene oxide (PEO)) in combination with slower-degrading materials (i.e. 
PCL), that can be quickly dissolved after spinning, leaving the non-soluble, slower-degrading 
polymer behind with larger pore sizes. 
In order to more closely tailor the properties of a scaffold—including biological, 
mechanical, and degradation characteristics—researchers have begun to combine two or more 
different components within a single scaffold. This can be done prior to electrospinning by 
mixing several polymers within a single solution, which results in a single fiber containing each 
component, or by electrospinning multiple solutions of polymers onto the same collector, thereby 
creating a scaffold with multiple fiber types.  
While natural polymer scaffolds composed of ECM proteins such as collagen and elastin 
show increased cellular response, when used alone they lack sufficient mechanical properties to 
function in the in vivo setting. Combining ECM derived from urinary bladder matrix with 
poly(ester-urethane)urea, Stankus et. al. were able to develop electrospun scaffolds with 
improved mechanical and biological properties than possible using the individual polymers 
alone.63 Similarly, Lee et. al. mixed collagen and elastin with several biodegradable synthetic 
polymers in order to develop scaffolds to utilize as vascular grafts. 
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Some polymers cannot be dissolved in the same solvent, therefore limiting the options for 
combining several different polymers within the same solution. Additionally, it may be desirable 
to utilize fibers of different dimensions or mechanical properties within the same scaffold. This 
has led to the development of multi-jet electrospinning in which different polymer solutions can 
either be electrospun at the same time to generate a homogeneous mixed scaffold or sequentially 
to generate a layered scaffold.64 For example, Baker, et. al. co-electrospun three different 
solutions containing polymers with varying degradation rates and mechanical properties to 
develop a scaffold that allowed for both improved cellular infiltration by increasing pore size 
over time as well as more closely mimicked the properties of the native tissue.65 
Electrospinning is a relatively simple, cost-effective technique that has shown significant 
potential in studies aimed at repair of many different types of tissues. When seeded with stem 
cells, nanofiber scaffolds have been shown to enhance differentiation towards many different cell 
types, including bone, cartilage, cardiac and skeletal muscle, blood vessels, and nerve.66,67 
1.3.6 Bioactive factors in tissue engineering 
While the scaffold structure plays an essential role in controlling cell behavior, chemical or 
biological modulators of cell activity and phenotype heavily influence tissue formation both in 
vitro and in vivo. In native tissues, growth factors provide specific signals to cells that direct cell 
activity including cell migration, proliferation, and differentiation. The effects of growth factors 
are quite complex and are dependent on the nature, active state, and concentration of the growth 
factor, phenotype of the target cell type(s), and functional characteristics of the specific cell 
receptor interacting with the growth factor. 
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In vitro tissue engineering studies often supply relevant growth factors in the culture 
medium to induce cellular differentiation. Transforming growth factor-beta (TGF-β) and bone 
morphogenetic proteins (BMPs) have been shown to have potential for inducing chondrogenesis 
in serum-free base medium also containing ascorbic acid and dexamethasone in vitro. On the 
other hand, MSC osteogenic medium typically contains fetal bovine serum (FBS) in addition to 
ascorbic acid, dexamethasone, and β-glycerophosphate. Vitamin D is also often added, in 
addition to β-glycerophosphate, to enhance matrix mineralization  during osteogenesis.69  
The concentrations and combinations of growth factors utilized can significantly affect 
cell growth and behavior, and synergistic effects of two or more growth factors may promote or 
inhibit differentiation of MSCs differently than when the growth factors are used independently. 
Additionally, culture conditions should be optimized for the specific type of cells, since cells 
from different tissue sources may respond differently to a specific growth factor cocktail. The 
importance and complexity of developing an optimal culture medium has led to a large number 
of research studies being performed that focus on examining the effects of different medium 
compositions on cell differentiation in vitro. 
1.3.7 Bone tissue engineering 
Electrospun scaffolds have been widely used in bone tissue engineering, demonstrating the 
ability to promote osteogenesis when seeded with either osteoblasts or stem cells. PCL nanofiber 
scaffolds with diameters of approximately 370 nm seeded with rat MSCs showed enhanced cell 
attachment and differentiation in comparison to flat substrates, with increased alkaline 
phosphatase activity, calcium deposition and expression of bone-specific matrix proteins, 
osteocalcin and osteopontin.70 Addition of proteins such as collagen to polymer scaffolds has 
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also been examined as a method for generating scaffolds with favorable material properties due 
to the synthetic scaffold, while increasing the bioactivity due to the protein coating. In one study, 
using PCL nanofibers coated with a collagen sheath resulted in increased calcium deposition by 
adipose-derived stem cells on scaffolds after two weeks in osteogenic medium,71 while another 
utilizing a chitosan/hydroxyapatite composite doped with collagen increased the osteogenic 
potential of fetal osteoblasts.72 Scaffolds containing a mixture of microfibers and nanofibers have  
also been examined for bone tissue engineering applications. Early studies showed that PCL 
scaffolds with fibers ranging from 20 nm to 5 µm seeded with rat MSCs had increased 
mineralization in vitro73 and in vivo.74   
While the above studies demonstrate the potential for cells to undergo osteogenesis on 
electrospun fibers, this approach may have limited potential in vivo. Bone contains a robust 
vascular network, with cells requiring the presence of a capillary within the 200 µm oxygen 
diffusion radius in order to survive in vivo.75 Previous work has shown that vascular invasion 
into porous scaffolds occurs very slowly, on the order of tenths of mm per day, 76 and smaller 
pores due to tissue deposition by other cells during in vitro culture may further slow the rate. 
Therefore, once implanted in vivo, the interior regions of a large tissue engineered bone construct 
without pre-vascularization would be unlikely to receive sufficient oxygen and nutrients, 
resulting in avascular necrosis and subsequent failure of the graft. 
Several approaches have been utilized to ensure successful vascularization of engineered 
bone. The first is to implant a cell-free scaffold in vivo in proximity to vasculature in order to 
induce blood vessel invasion. 77 The vascularized implant can then be extracted, seeded with 
osteogenic cells, and cultured in vitro before implanting the construct into the bone defect where 
it can be immediately anastamosed with the host vasculature. Limitations of this strategy include 
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the need for multiple invasive procedures as well as an inability to prevent invasion of non-
vascular cells during the initial in vivo culture period that may form unwanted tissue and inhibit 
later osteogenesis.  
Development of scaffolds containing angiogenic factors can also enhance recruitment of 
endothelial cells (EC) and promote blood vessel invasion into the scaffold.78 Due to advances in 
drug delivery techniques, the timing and rate of secretion of these growth factors from scaffolds 
can be relatively controlled. Alternatively, rather than adding growth factors directly, osteogenic 
cells could be genetically engineered to over-express specific angiogenic factors. This strategy 
eliminates need for an in vivo pre-vascularization step prior to seeding osteogenic cells. 
However, it is difficult to establish the optimal combination and release rate profile of growth 
factors that will promote a tightly controlled vascular invasion of the scaffold with formation of 
maturation, stable blood vessels within the scaffold, in addition to supporting bone formation by 
osteogenic cells. 
The above strategies cover potential in vivo approaches that rely on host blood vessels to 
be drawn towards and into the scaffold and induced to undergo branching angiogenesis in a 
controlled manner. During bone development and healing, there is evidence that osteoblastic 
precursors migrate with blood vessels, both as pericytes in tight association with endothelial cells 
and alongside the invading vascular front. Addition of ECs has been shown to induce MSCs to 
secrete increased amounts of VEGF, which upregulates EC secretion of BMP-2, causing 
enhancement of the osteogenic differentiation of MSCs cultured alone.79 This positive feedback 
loop suggests that ECs can directly promote osteogenic differentiation of MSCs in addition to 
initiating the establishment of a functional vascular network that will allow for successful 
survival and integration of the tissue. Futhermore, the perivascular location of MSCs in vivo 
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suggests that mutually enhancing interactions exist between MSCs and ECs. Therefore, another 
potential approach for bone tissue engineering is to induce blood vessel and bony tissue 
formation in vitro by co-culturing ECs or EC progenitors with osteogenic cells. The co-cultured 
construct can then be implanted into a bone defect, where the seeded ECs will elicit the initiation  
or maturation of a functional vascular bed that will anastamose with the host vasculature, thus 
providing the essential oxygen and nutrients to the interior tissue engineered bone construct, 
thereby preventing necrosis and promoting tissue integration. 
1.3.8 Cartilage tissue engineering 
The fibrous nature of the native collageneous matrix makes electrospinning an attractive method 
for fabrication of scaffolds for cartilage tissue engineering. Similar to findings in bone tissue 
engineering applications, studies have shown enhanced chondrogenesis of both MSCs and 
chondrocytes seeded onto electrospun PCL nanofibers fibers in comparison to flat surfaces.80,81 
Additionally, implantation of nanofibrous PCL scaffolds seeded with MSCs enhanced healing of 
a cartilage defect in a swine model.82  
Electrospinning can also be utilized to fabricate scaffolds with multiple orientations such 
as those seen in collagen fibers in different zones of articular cartilage. For example, one 
experiment utilized aligned electrospun PCL fibers designed to mimic the aligned orientation of 
collagen fibers seen in the superficial zone of cartilage, and showed potential for MSC 
chondrogenesis in vitro.83 In another study, a trilayer scaffold with an aligned superficial layer, 
and random middle and deep layers with increasing fiber diameters had improved mechanical 
properties compared to homogeneous scaffolds and supported MSC chondrogenesis.84 
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1.4 SUMMARY 
Understanding the interactions between cells and biomaterial scaffolds is essential for guiding 
the development of functional tissue engineered constructs for bone and cartilage engineering. 
Many variables including, but not limited to, media composition, scaffold composition, scaffold 
architecture, biomechanical stimulation, cell source, and cell seeding density must be optimized 
in order to develop a successful tissue engineered construct. It has been previously demonstrated 
that the cellular response to a biomaterial is not only dependent on the chemistry of the scaffold, 
but also on the architecture. Because of the structural similarity to the native ECM, electrospun 
fibrous scaffolds composed of either natural or synthetic polymers have become popular as 
biomaterials for cartilage and bone tissue engineering. Recent research suggests that cell 
behavior on these scaffolds is dependent on the diameter of the fibers, but findings among 
different researchers often seem to be contradictory due to the presence of non-controlled 
experimental parameters between studies. Additionally, while cartilage is an avascular tissue, 
bone requires vasculature to survive in vivo, necessitating co-culture of multiple cell types. 
Understanding the mechanisms that guide cell-material and cell-cell interactions may lead to 
improve strategies for designing functional tissue engineered bone and cartilage constructs. To 
this end, we performed the following investigations: 
 
Specific Aim #1: Determine the effects of fiber diameter and seeding density on chondrogenesis 
of MSCs on PCL scaffolds. 
 
Specific Aim #2: Determine the effects of fiber diameter and MSC tissue source on 
chondrogenesis and osteogenesis of MSCs on PCL scaffolds. 
  21 
Specific Aim #3: Determine the effects of sequential seeding on osteogenesis during co-culture 
of MSCs and endothelial cells on PCL fibrous scaffolds 
 
Our overall hypothesis is that by varying multiple culture parameters simultaneously in a 
systematic manner, we will obtain a more thorough understanding of the optimal conditions for 
promoting chondrogenesis and osteogenesis of MSCs on electrospun scaffolds that mimic the 
structural aspects of the native ECM. The following chapters detail the results of our experiments 
of each of the above specific aims. 
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2.0  EFFECTS OF SEEDING DENSITY AND FIBER DIAMETER ON 
CHONDROGENIC DIFFERENTIATION OF MESENCHYMAL STEM CELLS 
2.0 INTRODUCTION 
Several studies have examined the effects of electrospun scaffold fiber diameter on different cell 
types and tissue applications including bone, nerve,85–88 ligament,48,89 skin,90,91 blood vessels, and 
cartilage.83,92–94 The results of these studies suggest that the optimal fiber diameter may be highly 
dependent on various experimental factors and it may be impossible to isolate a single ideal fiber 
diameter independent of other conditions. For example, one study concluded that differentiation 
of mesenchymal stem cells (MSCs) towards a cartilage phenotype was better on electrospun 
poly(ε-caprolactone) (PCL) fibers that were 500nm in diameter than on fibers 3µm in diameter,83 
while another group concluded that chondrogenesis was enhanced on poly(L-lactide) fibers with 
diameters of 5µm or 9µm in comparison to those between 300nm and 1400nm in diameter.92 
While these studies appear to have conflicting results regarding the optimal fiber diameter for 
chondrogenesis, differences in other experimental parameters including differences in scaffold 
material, fiber alignment, medium composition, and initial cell seeding density may have 
contributed to the differences in outcome. 
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In tissue engineering studies, wide ranges of initial seeding densities have been 
examined. Seeding densities as low as 1x104 cells/cm3-scaffold up to 4x106 cells/cm3-scaffold 
have been used to examine MSC differentiation into a cartilage phenotype on fibrous 
scaffolds80,92. Even higher seeding densities, up to 100x106 cells/cm3-scaffold have been used 
when chondrocytes rather than stem cells were seeded, due to their reduced proliferation 
potential95. Higher seeding densities typically facilitate a greater amount of GAG and collagen 
produced per construct. However, some studies have found that there is a saturation point where 
further increases in the number of cells seeded do not result in increased matrix deposition or 
mechanical properties96,97, and in some cases may even lead to a decrease in matrix production 
on a per cell basis98,99.  
To begin to probe how induced chondrogenic differentiation of MSCs may be influenced 
by cell-cell and cell-biomaterial interactions, we have first examined the chondrogenic activity of 
human bone marrow-derived MSCs seeded onto electrospun PCL nanofiber and microfiber 
scaffolds. In addition, initial cell seeding density was also varied to determine if the number of 
cells on the scaffold influences the chondrogenic potential of the cells seeded onto scaffolds with 
fibers of different diameters. 
2.1 METHODS 
2.1.1 Scaffold Fabrication 
Nanofiber and microfiber PCL scaffolds were created by electrospinning using a custom made 
apparatus. PCL (80kDa, Sigma-Aldrich, St. Louis, MO) was dissolved at 40°C overnight in a 1:1 
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mixture of N,N-dimethylformamide and tetrahydrofuran (Fisher Scientific, Pittsburgh, PA) at a 
concentration of 11.5% and 22% w/v for nanofibers and microfibers, respectively. 0.06% w/v 
sodium chloride was added to the 11.5% solution to increase conductivity and improve 
homogeneity of fiber diameter. The polymer solution was drawn into a 20 ml syringe connected 
to a stainless steel needle. A syringe pump (Harvard Apparatus, Holliston, MA) was used to 
deliver the solution at constant rate of 2.0 ml/hr. Microfibers were electrospun using a 12-inch, 
18G blunt-ended needle charged to 8 kV with a high voltage power supply (Gamma High 
Voltage Research Inc., Ormond, FL) at a distance of 23 cm from the collector. For nanofiber 
scaffolds, a 4-inch, 22G blunt-ended needle was charged to 13.5 kV at a distance of 15 cm from 
the collector. The collector was a custom-made grounded aluminum mandrel rotating at 0.75 
m/s. Additionally, aluminum shields were placed on either side of the mandrel and plate and 
charged to either 10 kV or 2 kV for nanofibers and microfibers, respectively, in order to guide 
the fibers onto the grounded surface. A summary of these conditions is presented in Table 1. 
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Table 1. Electrospinning parameters of scaffold fabrication 
 
Fiber Type Nanofibers Microfibers 
PCL concentration  
(w/v) (%) 11.5 22.0 
Solution compositiona 1:1 DMF:THF + 0.06% NaCl 
1:1 
DMF:THF 
Needle size 
(gauge) 22 18 
Needle to mandrel 
distance 
(cm) 
15 23 
Voltage 
(kV) 13.5 8.0 
aDMF=Dimethylformamide (Fisher), THF=Tetrahydrofuran (Fisher) 
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2.1.2 Scaffold characterization 
The structure of microfibers and nanofibers was examined using scanning electron microscopy 
(SEM) (JSM6335F; JEOL, Peabody, MA). Scaffolds were mounted onto aluminum studs, 
sputter-coated with 3.5 nm of palladium/gold alloy, and imaged under an accelerating voltage of 
5 kV and a working distance of 8 mm. Image analysis for scaffold characterization was 
performed using a previously validated automated algorithm100. Briefly, the average pore size of 
the scaffolds was determined using SEM images by identifying and isolating the fibers on the 
surface of the image using a series of threshholding and filtering steps. The same software was 
also used to estimate fiber diameter by evaluating gradients in pixel intensities along points 
perpendicular to the fiber direction. 
2.1.3 Cell culture and seeding 
MSCs were isolated from bone marrow obtained from the femoral heads of patients undergoing 
total hip arthroplasty with approval from the Institutional Review Board (University of 
Washington, Seattle, WA and University of Pittsburgh, Pittsburgh, PA). Trabecular bone was 
isolated and the marrow was harvested using a bone curet and washed with DMEM containing 
10% fetal bovine serum (FBS) (Gibco, Carlsbad, CA). The marrow solution was then passed 
through a 40 µm filter into a 50 mL conical tube and centrifuged for 5 min at 1,100 RPM. The 
pellet that formed was washed with phosphate buffered saline (PBS), and cells were plated onto 
tissue culture-treated flasks. Cells were maintained in growth medium consisting of DMEM 
supplemented with 10% FBS and 1% antibiotic-antimycotic (anti-anti) (Gibco) at 37°C and 5% 
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CO2. Cells were passaged when they reached approximately 80% confluency using 0.5% 
trypsin/EDTA (Gibco), and all experiments were performed using passage 5 MSCs. Scaffolds 
were cut using a 1 cm diameter punch (McMaster-Carr, Elmhurst, IL) and then hydrated and 
sterilized in 70% ethanol for 2 hours. Scaffolds were then rinsed with PBS twice for 30 minutes 
each, and left overnight in growth medium. To seed MSCs onto scaffolds, cells were first 
trypsinized, resuspended and 50 µl of the solution was pipetted onto scaffolds to give initial cell 
seeding densities of 100,000 (100k), 500,000 (500k), 2,000,000 (2,000k) or 4,000,000 (4,000k) 
cells/cm3 of scaffold. Cells were allowed to attach for 2 hours prior to adding 1 ml of growth 
medium to each well of a 24-well plate coated with Sigmacote (Sigma).  
2.1.4 Chondrogenic differentiation 
After 24 hours of culture, growth medium was replaced with 2 ml of chondrogenic medium 
(Appendix A) and constructs were maintained at 37°C and 5% CO2. Medium was changed every 
3 days for 3 to 6 weeks prior to harvesting. 
2.1.5 RNA isolation and quantitative polymerase chain reaction (qPCR) 
Constructs from each group were rinsed with PBS, minced and placed into tubes. Six scaffolds 
were pooled into each tube in order to obtain sufficient RNA from low seeding density scaffolds. 
700 µl of TRIZOL (Invitrogen, Carlsbad, CA) was then added to each tube and the scaffolds 
were manually homogenized before storing at -80°C until the next step was performed. After 
addition of 140 µl of chloroform (Fisher Scientific), each solution was incubated at room 
temperature for 5 minutes prior to centrifuging at 12,000 rpm and 4°C for 15 min. One volume 
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of 70% ethanol was added to each sample followed by completing the RNA extraction using the 
RNeasy Micro Kit (Qiagen, Valencia, CA) following the manufacturer’s protocol. The 
concentration and purity of RNA was determined using a Nanodrop 2000c (Thermoscientific 
NanoDrop Technologies, Wilmington, DE). 200 ng of RNA from each sample was reverse 
transcribed into cDNA using the SuperScript III First-Strand Synthesis Super Mix (Invitrogen) 
following the manufacturers protocol using Oligo(dT)20 primers.  
Gene-specific primers were designed using Primer-Blast software (NIH, Bethesda, 
MD)101 and purchased from Integrated DNA Technologies (IDT, Coralville, IA). The primer 
concentrations and annealing temperatures were optimized for efficiency (95-105% efficiency) 
and specificity (melting curve analysis and product size by electrophoresis). Information for the 
genes analyzed (aggrecan, ACAN; collagen type II, COL2; collagen type I, COL1), including 
primer sequences, annealing temperatures, and concentrations, is provided in Appendix B. 
cDNA (10 ng) was added to 10 µl SYBR® Green PCR mastermix (Applied Biosystems, 
Carlsbad, CA) and 150 nM primers to a final volume of 20 µl and qPCR was performed using 
the StepOnePlus Real-Time PCR system (Applied Biosystems). After initial denaturation at 
95°C for 10 min, 40 cycles of 15 sec at 95°C and 1 min at the primer-specific annealing 
temperature were completed to amplify DNA. Quantification of the target gene expression, 
relative to the 100k nanofiber sample at each time point, was performed using the ∆∆CT method 
with cyclophilin A used as an endogenous control.  
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2.1.6 Biochemical Assays 
After washing with PBS, constructs were lyophilized and digested for 18 hours in 200 µl of a 
papain solution (125 µg/ml papain, 50 mmol sodium phosphate buffer, 2 mmol N-acetyl cysteine 
(Sigma), pH 6.5). Following digestion, samples were stored at -20°C. The DNA content in the 
scaffolds was quantified using the Quant-iT PicoGreen dsDNA Assay Kit (Invitrogen), following 
the manufacturers protocol. The fluorescence of the PicoGreen-DNA solution was measured 
using a Synergy HT plate reader (BioTek, Highland Park, VT) at an excitation/emission of 
485/528 nm, and DNA content in the samples was estimated using the DNA standard provided in 
the kit. Quantification of sulfated GAGs in the scaffolds was performed using a commercial 
Blyscan Glycosaminoglycan Assay kit (Accurate Chemical & Scientific, Westbury, NY). The 
absorbance at 656nm was measured using a plate reader and a chondroitin-4-sulfate solution 
provided with the kit was used as a standard. The collagen content of the scaffolds was 
determined using a modified hydroxyproline assay102 using bovine collagen type I as a standard. 
Briefly, each sample and standard were hydrolyzed with 125 µl of 4N sodium hydroxide (Fisher) 
at 121°C for 20 min. 125 µl of 4N hydrochloric acid (Fisher) added added and the solution was 
titrated to a neutral pH. 187.5 µl of chloramine-T solution (Sigma) (14.1 g/L chloramine-T, 50 
g/L citric acid, 120 g/L sodium acetate trihydrate, 34 g sodium hydroxide, 0.21M acetic acid) 
was incubated with the sample at room temperature for 25 min followed by addition of 187.5 µl 
of 15 g/L p-dimethylaminobenzaldehyde in 2:1 isopropanol:perchloric acid and incubation in a 
60°C water bath for 20 min. Finally, 200 µl of each sample in triplicate was added into a 96 well 
plate and absorbance was read at 550 nm.   
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2.1.7 Immunofluorescence & confocal laser scanning microscopy 
Whole mounts were utilized for examination of matrix components. Briefly, constructs were 
fixed in 4% paraformaldehyde for 20 minutes, washed, and stored in PBS at 4°C until staining 
was performed. 
Details about primary and secondary antibodies used can be found in Appendix C. Prior 
to antibody application, enzymatic antigen retrieval was performed, with constructs incubated in 
0.1% pepsin in 0.01 HCl, pH 3.0 for 20 minutes at 37°C to unmask antigens. Following retrieval, 
non-specific antibody binding was blocked with 5% normal goat serum (Vector) for 1 hour, 
followed by incubation with primary antibodies for collagen types I and II overnight at 4°C. 
Following washing with 0.5% bovine serum albumin in PBS, scaffolds were then incubated for 1 
hour with the appropriate AlexaFluor fluorescent secondary antibodies (Invitrogen). Nuclei were 
stained using 40,6-diamidino-2-phenylindole (DAPI; 1:10000; Invitrogen) for 2 minutes. 
Negative controls included omission of the primary antibody as well as species-specific isotype 
controls. 
Scaffolds were imaged by confocal laser scanning microscopy (CLSM; Fluoview 1000; 
Olympus, Center Valley, PA) and image processing and analysis were performed using NIS 
Elements software (Nikon Instruments, Inc., Melville, NY). Scaffolds were cut in half and nuclei 
were examined in cross-section in order to visualize the cell distribution through the scaffold 
thickness. Stacks of 10 images were acquired with 5 µm between each image and flattened. A 
separate image was acquired by increasing the laser intensity until scaffold autofluorescence was  
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sufficient to visualize the edge of the scaffold. The distance between the edge of the scaffold and 
the deepest nucleus was measured to determine the overall depth of cell penetration from the 
scaffold surface. 
En face imaging of scaffolds to detect collagen types I and II, and to quantify cell density 
was also performed using CLSM. Images for nuclear quantification were taken 20µm deep in 2 
µm increments, while staining for collagen types I and II were visualized simultaneously to 
determine their respective distributions on the scaffold. Three images on different scaffolds were 
acquired and the number of cells was counted to determine the overall cell density as well as 
examine the collagen distribution. 
2.1.8 Statistical Analysis 
All data were expressed at mean ± standard deviation. Statistical analysis was performed using 
two-way analysis of variance with Tukey’s post-hoc test for multiple comparisons. A threshold 
of p<0.05 was used to determine statistical significance. 
2.2 RESULTS 
2.2.1 Scaffold characterization 
Electrospun nanofiber scaffolds had an average of diameter of 445±173 nm, an average pore size 
of 1.2 µm2 and an overall porosity of 88%, while microfiber scaffolds had average diameter of 
4.37±0.78 µm, an average pore size of 91 µm2, and an overall porosity of 90% (Figure 1). 
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Figure 1. SEM of nanofibers and microfibers 
(A) Nanofiber scaffolds have a diameter of 445±173 nm and an average pore size 
of 1.2 µm2.  (B) Microfiber scaffolds have a diameter of 4.37±0.78 µm and an 
average pore size of 91 µm2 Images were taken at 1000x magnification. Scale 
bars =10µm. 
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2.2.2 Gene expression 
At 3 and 6 weeks following induction of chondrogenic differentiation, ACAN expression was 
significantly higher overall when cells were seeded on microfibers in comparison to nanofibers 
(Figure 2a,b). Within each initial seeding density, post-hoc analysis showed significant 
differences at week 3 between microfibers and nanofibers in the two higher seeding density 
groups, and expression was significantly greater with an initial seeding density of at least 2,000k 
cells/cm3 than in the lower seeding density groups, although no significant differences were 
found between 2,000k and 4,000k groups. At week 6 there were no significant differences 
between expression in 500k, 2,000k and 4,000k microfiber groups, and while 500k and 2,000k 
groups had higher ACAN expression on microfibers than nanofibers, while there was seemingly 
no difference in expression between nanofibers and microfibers at the 4,000k seeding density.  
COL1 and COL2 gene expression at week 3 followed a similar trend, with higher seeding 
densities showing increased expression on microfibers in comparison to nanofibers. At week 6, 
however, COL1 expression was similar in microfibers and nanofibers in the 2,000k group and 
significantly decreased on microfibers in the 4,000k group, while COL2 expression remained 
high (Figure 2c-f). Finally, the COL2/COL1 ratio, where high values indicate a more hyaline 
cartilage phenotype, was significantly greater at both 3 and 6 weeks for the higher seeding 
densities on microfibers than nanofibers and in comparison to the lower seeding densities (Figure 
2g,h). 
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 Figure 2. Gene expression on microfiber and nanofiber scaffolds at different 
seeding densities. 
Quantification of relative mRNA expression for chondrogenic markers after 3 and 
6 weeks of culture. Fold change differences in gene expression normalized to the 
100k cells/cm3-scaffold group at each time point. COL2/COL1 ratio represents 
the ratio of COL2 to COL1 expression. *p<0.05, n=3. 
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2.2.3 Biochemical characterization 
There were no significant differences in DNA content seen between microfiber and nanofiber 
groups on Day 1 after seeding (Figure 3a). However, the DNA content in scaffolds at week 3 
was significantly higher overall in microfibers than nanofibers, and significantly more DNA was 
found in microfiber than nanofiber constructs in the high initial seeding density group (Figure 
3b). There was also no significant difference between the amount of DNA in the 2,000k and 
4,000k groups seeding on scaffolds with the same fiber diameter. A similar trend was seen in 
week 6, with a significantly higher amount of DNA also found on microfibers in the 500k group 
(Figure 3c). 
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 Figure 3. DNA content for microfiber and nanofiber scaffolds at different 
seeding densities. 
(A) 1 day, (B) 3 weeks, and (C) 6 weeks after seeding. *p<0.05, n=6. 
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GAG production paralleled the DNA content at the week 3 time point, with significantly 
more GAG being produced by high seeding density microfiber groups (Figure 4a). However, 
there was no significant difference when the GAG was normalized to DNA content, suggesting 
that on a per cell basis, there were similar amounts of GAG production on the different scaffold 
times (Figure 4c). The GAG production at week 3 in the 100k or 500k groups was below the 
level of detection of the assay and thus was excluded in the analysis. At week 6, both the total 
GAG and the GAG/DNA values were significantly higher in the 2,000k and 4,000k groups 
(Figure 4b). The 500k group produced enough GAG to meet the assay’s threshold of detection at 
the 6 week time point, and while the total GAG production was lower than the higher seeding 
density groups, the GAG/DNA in the 500k group was not significantly different at 6 weeks than 
the 2,000k group (Figure 4d). 
 
 
 
  38 
 Figure 4. GAG deposition on microfiber and nanofiber scaffolds at different 
seeding densities 
Total GAG/scaffold at (A) 3 weeks and (B) 6 weeks. GAG normalized to DNA at 
(C) 3 weeks and (D) 6 weeks. *p<0.05, n=6. 
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Trends in total collagen production and collagen/DNA were similar to those seen with 
GAG production, with the addition of the 500k group having significantly higher collagen 
deposition on microfibers than nanofibers at week 6 both in terms of total collagen and 
collagen/DNA. Furthermore, there were no significant differences seen in the amount of 
collagen/DNA in any of the detectable groups seeded on microfibers. 
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Figure 5. Collagen deposition on microfiber and nanofiber scaffolds at 
different seeding densities 
Total GAG/scaffold at (A) 3 weeks and (B) 6 weeks. GAG normalized to DNA at 
(C) 3 weeks and (D) 6 weeks. *p<0.05, n=6. 
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2.2.4 Cell distribution and matrix deposition 
Cross-sectional views of scaffolds stained nuclei are shown in Figure 6. While cells were found 
to be present throughout the entire depth of the microfiber scaffolds, on nanofiber scaffolds they 
were restricted to the scaffold surface. The depth of penetration of cells on nanofibers was 
approximately 25 µm for both 100k and 500k groups, while cells penetrated somewhat deeper 
with higher seeding densities, reaching depths of ~50 and 85 µm for the 200k and 400k groups, 
respectively. 
Scaffolds seeded with 100k or 500k cells/cm3-scaffold stained positively for collagen 
type I around sparse nuclei, but were negative for collagen type II (Figure 7). At high seeding 
densities, collagen type I aligned parallel to the surface of the scaffold was seen on all groups 
(Figure 8). Only nanofibers seeded at the highest density stained positively for collagen type II, 
while both the 2000k and 4000k microfiber groups appeared to have similar amounts and 
structure of collagen type II deposition. Images taken at the edge of 4,000k nanofiber and 
microfiber groups display some differences in the arrangement of collagen fibers. While collagen 
type II staining appears to be mainly on the surface of microfibers, with collagen type I below, 
the collagen type II staining appears to be mixed within the same layer as the collagen type I on 
nanofiber scaffolds (Figure 9). 
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Figure 6. Cross-sections of scaffolds with fluorescently stained nuclei to 
evaluate cell penetration 
Nuclei are stained with DAPI (blue). White lines indicate the edge of the scaffold. 
Images taken at 10x, scale bar = 200 µm. 
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Figure 7. Confocal fluorescence microscopy images of scaffolds with low 
initial cell seeding density. 
Nanofibers seeded with 100k (A-C) and 500k (D-F) cells/cm3-scaffolds and 
microfibers seeded with 100k (G-I) and 500k (J-L) cells/cm3-scaffolds. And 
stained for collagen type I (green) and collagen type II (red). Nuclei are stained 
with DAPI (blue) in the merged image. Images taken at 40x, scale bar = 50 µm. 
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Figure 8. Confocal fluorescence microscopy images of scaffolds with high 
initial cell seeding density. 
Nanofibers seeded with 2000k (A-C) and 4000k (D-F) cells/cm3-scaffolds and 
microfibers seeded with 2000k (G-I) and 4000k (J-L) cells/cm3-scaffolds. And 
stained for collagen type I (green) and collagen type II (red). Nuclei are stained 
with DAPI (blue). Nuclei are stained with DAPI (blue) in the merged image. 
Images taken at 40x, scale bar = 50 µm. 
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Figure 9. Collagen organization on edge of scaffolds seeded with a high initial 
cell density after 6 weeks 
(A) Nanofibers with 4000k cells/cm3-scaffold; (B) Microfibers with 4000k 
cells/cm3-scaffold; Collagen type I (green), Collagen type II (red), DAPI (blue); 
Images taken at 40x, scale bar = 50 µm 
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2.3 DISCUSSION 
Previous studies examining the effects of fiber diameter on chondrogenesis are difficult to 
compare due to variations not only in the fiber diameters and cell seeding densities used, but also 
other variables including the scaffold material, fiber alignment, cell type, medium composition, 
time points analyzed, and the methods used to determine the outcomes. Thus, although the 
results between studies may appear to be conflicting, with some suggesting that nanofibers 
induce better cartilage formation than microfibers while others conclude the opposite, these 
differences could in fact be attributable to other experimental variables that are not controlled for 
between studies. The results of this study suggest that scaffold diameter plays an important role 
in the chondrogenic differentiation of MSCs on PCL scaffolds in vitro. Furthermore, the effects 
of varying the fiber diameter are dependent on the initial cell seeding density.  
Under the culture conditions utilized in this study, using microfiber scaffolds and higher 
cell seeding densities resulted in optimal chondrogenesis. This is likely in part due to differences 
in pore size between microfiber and nanofiber scaffolds. While the overall porosities of the 
scaffolds were similar, the average pore size of nanofiber scaffolds was approximately 75 times 
smaller than microfiber scaffolds. Since the average diameter of human MSCs in suspension is 
approximately 10-20µm,103,104 it is unlikely cells would be able to penetrate into a scaffold with a 
pore size of only 1.2 µm2 and thus would require significant modification of the scaffold 
organization to migrate to the center of the scaffold. In this experiment, only between 2% and 
10% of the scaffold thickness was colonized by MSCs on nanofibers, while cells seeded onto the 
microfiber scaffolds containing larger pores were able to migrate throughout the entire depth of 
the scaffold and establish a relatively homogeneous cell distribution with high seeding densities.  
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In effect, reducing the pore size severely limits the surface area to which cells can attach, and 
may provide a partial explanation for the reduced tissue formation on nanofibers in comparison 
to microfiber scaffolds.  
The first cellular step in mesenchymal chondrogenic differentiation is condensation of 
MSCs into high-density cell aggregates. Formation of these cell-cell contacts are mediated by 
adhesion molecules such as N-cadherin and N-CAM, and are essential for successful cartilage 
formation.4 Following formation of these interactions, cells undergo commitment to the 
chondrogenic lineage and begin expression the transcription factor Sox9. When cells are seeded 
at a very low density, the potential for cell-cell interactions is limited, and therefore 
chondrogenic differentiation is likely to be reduced. In this study, seeding cells at a very low 
density (100k cells/cm3-scaffold) resulted in low chondrogenic gene expression and protein 
production. There were no significant differences in chondrogenic gene expression or cell 
number between microfiber and nanofiber scaffolds, and the amounts of secreted collagen and 
GAG were not sufficient to be detected with the assays utilized. Immunofluorescence showed 
limited collagen type I deposition and staining for collagen type II was absent, with no apparent 
differences between microfiber and nanofiber scaffolds. These results therefore suggest that low 
seeding densities have limited utility for studying chondrogenesis on electrospun fibers, 
independent of the scaffold diameter.  
During articular cartilage development, ECM composed of collagen type I in addition to 
other cell-adhesion molecules is initially deposited by MSCs prior to differentiation4,105. This 
profile of collagen type gene expression is thus different from that seen in the forming 
endochondral cartilage growth plate, where collagen type II expression is dominant. As 
differentiation commences following condensation, a shift towards a phenotype with high 
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collagen type II and proteoglycan deposition occurs. A similar pattern is seen in this experiment 
with microfiber constructs seeded at high initial cell densities. Gene expression of COL1 in 
addition to COL2 and ACAN is higher on microfibers at the 3-week time point, suggesting that 
cells may still be in a somewhat proliferative state, but are shifting towards differentiation and 
increased collagen type II and proteoglycan production. Confirmation of this is seen after 6 
weeks in culture, where expression of COL1 on microfibers decreases in comparison to 
nanofibers. GAG and collagen protein deposition follow a similar pattern to gene expression, and 
immunofluorescence staining shows the presence of collagen type II on the surface of the 
construct in addition to collagen type I. In comparison, cells seeded on nanofibers also stain 
positively for both type I and collagen type II, but seem to have less collagen type II than 
microfibers. Thus, it appears that at high initial cell seeding densities, the microfibrous PCL 
scaffolds used in this study more efficiently promote an articular cartilage phenotype and related 
ECM protein deposition than nanofibrous scaffolds.   
While seeding densities of 2,000k cells/cm3-scaffold and higher appear to be superior for 
chondrogenesis, the lower seeding densities also provide some insight into cell behavior on 
scaffolds of different diameters. Adult human articular cartilage has an overall cell density of 
approximately 20x106 cells/cm3, while newborns may have cell densities that are 6-7 times 
higher.106 The cell density near the surface of the scaffolds after 6 weeks of culture was between 
adult and newborn values on both nanofibers and microfibers for all groups except for the 100k 
seeding density group, suggesting that seeding densities of 500k cells/cm3-scaffold or higher are 
likely to be needed for successful regeneration of cartilage tissue using MSCs.  
 
 
  49 
After 6 weeks of culture, chondrogenic gene expression in the 500k group on microfibers 
increased to levels similar to the higher density groups and GAG and collagen production 
increased, indicating that chondrogenic differentiation is delayed at this seeding density, but can 
be induced over time. This delayed chondrogenic induction may be attributable to the number of 
cells reaching a threshold in cell density where enough cell-cell contacts are formed to induce 
chondrogenesis, and therefore stimulate increased expression of ACAN and COL2 as well as 
increased GAG and collagen deposition.  
There were no significant differences in the number of cells attached to microfiber and 
nanofiber scaffolds one day after seeding. This suggests that the greater number of cells as well 
as higher chondrogenic gene expression and protein production on microfibers are due to 
differences in the scaffold architecture that influence cell behavior and are not simply a direct 
result of the seeding efficiency being higher for microfiber scaffolds. One explanation is that 
while both of the high-density seeding groups have a cell density sufficient to induce 
chondrogenesis, the presence of cells throughout the entire thickness of the microfibers results in 
a larger area for cells to migrate and deposit ECM. Since cells cannot migrate deeply into the 
nanofiber scaffold, tissue deposition is restricted to the surface. During the early periods of 
culture, cells on both types of scaffolds deposit ECM molecules at a similar rate due to an 
abundance of space surrounding each cell. However, with the reduced pore size, cells seeded on 
nanofibers have a limited area to which they can migrate, and may become surrounded by the 
ECM more quickly. This may lead to slowing of matrix protein secretion, thus resulting in 
decreased GAG and collagen per cell in comparison to microfiber constructs seen at the 6-week 
time point.  
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Another potential contributor to the enhanced chondrogenesis on microfibers may be that 
even though the overall void area is similar in microfibers and nanofibers, the architecture of the 
microfiber scaffolds promotes the clustering of cells between fibers while cells seeded on 
nanofibers are more likely to attach and spread out across fibers, limiting their interactions with 
other cells. The reduced cell-matrix communications and the forced clustering due to the fiber 
spacing may result in promotion of the cell-cell interactions that are required for induction of 
chondrogenesis. This phenomenon was also considered in a previous study examining cell 
behavior on PLLA scaffolds having different diameter and pore sizes, with MSC chondrogenesis 
enhanced on larger fibers with larger average pore size.92 Studies conducted in our laboratory 
and by others have shown enhanced chondrogenic gene expression and a more round cellular 
morphology, characteristic of those cells found below the superficial zone of native cartilage, 
when chondrocytes are seeded onto nanofiber scaffolds than nanofiber scaffolds.93,94 However 
this may be an effect of the phenotype of the cells, with chondrocytes benefiting from being 
exposed to a nanofibrous environment more similar to that seen in the native cartilage matrix, 
while MSC differentiation is enhanced under conditions similar to those found during 
development. Increasing the cell seeding density would increase the initial packing of cells 
between microfibers, thus promoting chondrogenesis in the higher seeding density groups in 
comparison to the lower seeding groups.  
Cell morphology on scaffolds may also provide some insight into the differences in cell 
behavior on microfiber and nanofiber scaffolds. In native cartilage, the superficial zone is a thin 
layer containing flattened chondrocytes, while in the intermediate and deep zones chondrocytes 
are more round. A similar morphology is found on microfiber scaffolds seeded at high cell 
densities. In contrast, cells seeded on nanofiber scaffolds appear to mostly form a thicker layer of 
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flattened superficial zone-like cells near the surface of the scaffold. In vivo, the cells of the 
intermediate and deep zones are the main synthesizers of proteoglycans, which could explain the 
decreased GAG formation in these scaffolds, and there is also evidence that collagen expression 
is higher in these areas as well.107  
The results of this study strongly suggest that seeding MSCs onto microfibers promotes 
chondrogenesis better than nanofibers, although it remains unclear whether the differences are 
simply due to increased pore size leading to enhanced cell penetration, or if other aspects of the 
scaffold architecture are influencing differentiation. Additionally, while studies often utilize 
lower seeding densities to reduce cell-cell interactions and increase cell-material interactions to 
understand the role of materials on cell behavior, this may not be useful in cartilage tissue 
engineering applications due to the importance of the cell-cell interactions in inducing 
chondrogenic differentiation. Future studies seeding MSCs at high densities onto microfiber and 
nanofiber scaffolds fabricated to have similar pore size may provide additional insight into 
optimal environmental conditions for developing a tissue engineered cartilage construct.  
2.4 CONCLUSION 
In conclusion, utilizing the three-pronged approach to tissue engineering strategies combining 
scaffolds, cells, and other bioactive stimulants creates a large number of potential variables that 
can influence experimental outcomes and makes comparing between studies difficult. In this 
experiment, we examined two variables at the same time—seeding density and fiber diameter— 
in order to more fully understand the role that each of these variables play in influencing 
interactions that occur between MSCs and electrospun fibers under in vitro chondrogenic 
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conditions. Our findings suggest that seeding MSCs at a high initial density onto a microfibrous 
scaffold that facilitates cell-cell interactions while allowing for cells to migrate throughout the 
entire thickness, stimulates chondrogenesis in vitro more effectively in comparison to using 
nanofiber scaffolds and/or low seeding densities.  
If only low seeding densities had been utilized in this study, it may have been concluded 
that the fiber diameter was unimportant for chondrogenesis. Or, if only nanofibers had been 
utilized, the knowledge gained by understanding the potential importance of pore size and cell 
infiltration in conjunction with seeding density would have been lost. While it is not feasible to 
test all potential combinations of culture parameters at once, understanding the interplay between 
different parameters by examining multiple variables may be a beneficial strategy in attempting 
to a successful tissue engineered construct. 
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3.0  EFFECTS OF CELL SOURCE AND FIBER DIAMETER ON CHONDROGENIC 
AND OSTEOGENIC MESENCHYMAL STEM CELL DIFFERENTIATION 
3.0 INTRODUCTION 
In Section 2 above, we demonstrated that the fiber diameter plays an important role in 
chondrogenesis of BMSCs on PCL scaffolds. In addition to the scaffold, choosing the optimal 
cell type is essential. MSCs are an attractive cell source since they can be obtained either 
autologously or allogenically, differentiated into multiple cell types, and expanded in vitro while 
maintaining their multipotential character. Additionally, mimicking the in vivo developmental 
process may enhance tissue formation, and MSCs are the precursors to the terminally 
differentiated cells found in musculoskeletal tissues including bone and cartilage. MSCs have 
been isolated from several different locations including bone marrow, adipose tissue, synovium, 
muscle, and umbilical cord and peripheral blood108. BMSCs are the most commonly used type of 
MSC, with excellent differentiation potential and even immunomodulatory and 
immunosuppressive properties. However, isolation of bone marrow is a painful procedure that 
carries some risk, and the isolation efficiency is low, necessitating in vitro expansion to obtain 
sufficient cell numbers. Another source of MSCs that is gaining popularity are adipose-derived  
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stem cells (ADSCs). ADSCs are an appealing cell source for tissue engineering of 
musculoskeletal tissues due to ease of obtaining large quantities of cells which reduces the time 
needed for in vitro culture, along with minimal risk and discomfort caused by the procedure. 
Previous studies have shown that both BMSCs and ADSCs have the ability to undergo 
chondrogenic, osteogenic and adipogenic differentiation109. Some past reports have suggested 
that ADSCs do not undergo as robust chondrogenesis as BMSCs110–112. However, other studies 
have shown that this limitation can be overcome by altering the media composition, specifically 
by including BMP-2 or BMP-6 in addition to TGF-β in the cell culture medium113–116. Similarly, 
BMSCs have been suggested to have greater osteogenic potential than ADSCs109,117,118. 
However, all of these studies were performed in monolayer and not in 3D culture. Only a few 
studies have examined the chondrogenic and osteogenic potential of ADSCs on electrospun 
scaffolds71,119–122, and none have compared BMSCs and ADSCs, nor the effects of fiber diameter 
on ADSC differentiation.  
In this study, we investigated the effects of fiber diameter and MSC source on both 
chondrogenesis and osteogenesis in order to determine if the cell source or fiber diameter affects 
the formation of tissue engineered cartilage or bone constructs.  
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3.1 MATERIALS & METHODS 
3.1.1 Electrospinning 
PCL (80 kDa, Sigma-Aldrich, St. Louis, MO) microfiber and nanofiber scaffolds were fabricated 
using a custom-made electrospinning device as previously described in Section 2.2.1. Fibers 
were collected on the electrically grounded mandrel until the sheets reached approximately 1 mm 
in thickness.  
 
3.1.2 Scaffold characterization 
Images of microfibers and nanofiber scaffolds were taken by SEM and the pore size and fiber 
diameter were analyzed using an automated algorithm as described in Section 2.2.2. 
3.1.3 Cell culture 
Bone marrow-derived MSCs (BMSCs) were isolated using a standard technique based on 
adhesion to tissue culture plastic as described previously in section 2.2.3.  
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Adipose-derived stem cells (ADSCs) were isolated with IRB approval (University of 
Pittsburgh, Pittsburgh, PA) from donor lipoaspirate using the automated Icellator Cell Isolation  
System (Tissue Genesis, Honolulu, HI). The isolated cells were seeded into tissue culture flasks 
and cultured in proliferation medium composed of DMEM with 10% FBS and 1% antibiotic-
antimycotic. 
For each cell type, cells from three age- and sex-matched donors (females age 28 to 55 
years of age) were pooled at passage 1. During expansion, when cells reached approximately 
80% confluency, they were detached from flasks with 0.5% trypsin/EDTA (Gibco), pelleted, 
resuspended and reseeded at 5x103 cells/cm2 in fresh proliferation medium.  
3.1.4 Cell seeding 
1 cm diameter scaffolds were cut and hydrated as described in section 2.2.3. Passage 5 cells were 
pipetted onto the scaffold surface at a density of 2x106 cells/ml of scaffold in 50 µl of medium. 
Constructs were placed into individual wells of non-treated 24-well plates coated with Sigmacote 
(Sigma, St. Louis, MO) and incubated for 2 hours to allow for cell adhesion, followed by 
addition of 1 ml of proliferation medium to each well. The following day, the proliferation 
medium was replaced with 2 ml of either chondrogenic medium or osteogenic medium Appendix 
A to induce differentiation. Medium was changed every 3 days and constructs were harvested 
after 3 and 6 weeks of culture.   
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3.1.5 RNA isolation and qPCR 
RNA isolation, reverse transcription, and qPCR assays were performed as described in section 
2.2.4, with six constructs pooled into each tube to obtain ample quantities of RNA. Relative 
expression of chondrogenic and osteogenic genes was determined using validated primers 
(Appendix B) and the ∆∆CT method, with cyclophilin A as the endogenous control.  
3.1.6 Assays for Chondrogenesis 
The DNA, GAG and collagen content of scaffolds that underwent chondrogenic differentiation 
were determined in the manner described in Section 2.2.6. Commercial PicoGreen and Blyscan 
assay kits were used to determine quantities of DNA and GAG, respectively, while the modified 
hydroxyproline assay was used to quantify overall collagen production. 
3.1.7 Assays for Osteogenesis 
Samples cultured in osteogenic differentiation medium were rinsed in PBS, blotted gently on 
filter paper, and placed into tubes containing 500 µl of 2% Triton-X lysis buffer and frozen at -
80°C. Samples were then subjected to three freeze-thaw cycles of 30 minutes at 37°C followed 
by 30 minutes at -80°C and sonicated for 10 seconds. 
DNA content was determined using the PicoGreen assay described above. Alkaline 
phosphatase activity was determined using the Sensolyte pNPP assay kit, following the 
manufacturers recommendations (Anaspec, Fremont, CA).  
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In order to determine the calcium content of scaffolds, an equal volume of 1 N acetic acid 
was added to the remaining solution in the sample tube and left overnight with gentle agitation in 
order to dissolve calcium into solution. 30 µl of samples and CaCl2 standards (Sigma) with 
concentrations ranging from 0 to 100 µg/ml were added to 300 µl of Arsenazo III reagent (Pointe 
Scientific (Canton, MI) in a 96-well plate and read at 650 nm.123 
3.1.8 Immunofluorescence 
Whole constructs were utilized for immunofluorescence staining in order to examine tissue 
structure in three dimensions. Constructs were fixed with 4% paraformaldehyde for 20 minutes 
followed by immunofluorescence detection using antibodies to chondrogenic (aggrecan, collagen 
type I, collagen type II) or osteogenic (collagen type I, osteocalcin, osteonectin)  markers 
(Appendix C). After performing the necessary antibody-specific antigen retrieval and/or cell 
permeabilization steps, non-specific binding of antibodies in samples was blocked with 5% goat 
serum for 30 minutes. Constructs were then incubated with primary antibodies overnight at 4°C, 
followed by detection with fluorescently tagged secondary antibodies. Three-dimensional stacks 
of images were obtained using confocal scanning laser microscopy and images were processed 
using NIS Elements. 
3.1.9 Statistics 
Quantitative outcome measures for biochemical assays are expressed as mean ± standard 
deviation. Statistical analysis was performed using a two-way analysis of variance, followed by 
Tukey’s test for post-hoc comparisons. p<0.05 was considered statistically significant. 
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3.2 RESULTS 
3.2.1 Scaffold characterization 
The scaffolds utilized in this study had the same physical characteristics as those used in Chapter 
2.3.1. Nanofiber scaffolds had a diameter of 445±173 nm, average pore size of 1.2 µm2, and 
overall porosity of 88%. Microfiber scaffolds had a diameter of 4.37±0.78 µm, average pore size 
of 91 µm2, and overall porosity of 90%.  
3.2.2 Chondrogenic gene expression 
qPCR was performed on nanofiber and microfiber scaffolds seeded with either BMSCs or 
ADSCs to determine gene expression for COL1, COL2, and ACAN to assess the chondrogenic 
differentiation of cells after 3 weeks (Figure 10) and 6 weeks (Figure 11). Overall, chondrogenic 
gene expression was higher for BMSCs than ADSCs, and on microfibers than on nanofibers.  At 
the 3-week time point, COL2 expression was 3-fold higher and 8-fold higher on microfibers than 
nanofibers for BMSCs and ADSCs, respectively. ADSCs had a 6-fold higher expression of 
ACAN when seeded on microfibers in comparison to nanofibers, while fiber diameter altered 
ACAN expression in BMSCs modestly, with 1.8-fold higher expression on microfibers than 
nanofibers.  COL1 expression at 3 weeks was highest when ADSCs were seeded on microfibers, 
with no differences between nanofibers and microfibers seeded with BMSCs. The ratio of COL2 
to COL1 expression was highest for BMSCs seeded on nanofibers, while the ratio was much 
lower for ADSCs, particularly those seeded on nanofibers. 
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 Figure 10. Chondrogenic gene expression after 3 weeks in culture 
Fold change in gene expression at week 3 normalized to the BMSC nanofiber 
group. (A) Collagen type I, (B) Collagen type II, (C) Aggrecan; (D) Ratio of 
collagen type I to collagen type II expression. *,#,a,b,cp<0.05, n=3. 
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 Figure 11. Chondrogenic gene expression after 6 weeks of culture 
Fold change in gene expression at week 3 normalized to the BMSC nanofiber 
group. (A) Collagen type I, (B) Collagen type II, (C) Aggrecan; (D) Ratio of 
collagen type I to collagen type II expression. *,#,a,bp<0.05, n=3. 
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3.2.3 Osteogenic gene expression 
Gene expression for COL1, osteonectin and osteocalcin was evaluated after 3 and 6 weeks of 
culture in osteogenic medium (Figure 12). ADSCs had an approximately 10-fold increase in 
COL1 expression after 3 weeks on both microfiber and nanofibers in comparison to BMSCs on 
nanofibers, while BMSCs on microfibers had a 4-fold increase in COL1 expression. After 6 
weeks of osteogenic culture COL1 expression was less than 2-fold different between all groups. 
Osteonectin expression was approximately 2-fold higher on BMSCs seeded on nanofiber and 
ADSCs seeded on microfibers than BSMCs on microfibers and ADSCs on nanofibers after 3 
weeks, but after 6 weeks of culture, osteonectin expression was 5-fold higher in BMSCs on 
microfibers, while ADSCs had approximately 7- and 10-fold higher osteonectin expression on 
nanofibers and microfibers respectively. Osteocalcin expression was about 9-fold higher in 
BMSCs seeded on nanofibers than in ADSCs seeded on microfibers or nanofibers, and twice that 
of BMSCs on nanofibers at 3 weeks. After 6 weeks, this relationship was also altered, with cells 
seeded on microfibers having higher gene expression than cells on nanofibers. ADSCs had over 
a 20-fold increase in osteocalcin gene expression when seeded onto microfibers rather than 
nanofibers. BMSCs had a more measured response, increasing gene expression approximately 3-
fold when seeded on microfibers rather than nanofibers.  
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 Figure 12. Osteogenic gene expression after 3 and 6 weeks of culture 
Fold change in gene expression of collagen type I (A,B), osteonectin (C,D), and 
osteocalcin (E,F) normalized to the BMSC nanofiber group at week 3 (A, C, E) 
and week 6 (B, D, F). *,#,a,b,cp<0.05, n=3. 
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3.2.4 Biochemical characterization of chondrogenesis. 
The cellularity, GAG and collagen content was compared between groups following 
chondrogenic differentiation. At 3 weeks, DNA quantification by PicoGreen showed a higher 
number of BMSCs than ADSCs on each type of scaffold (Figure 13). ADSCs seeded on 
nanofibers had significantly fewer cells than BMSCs on either nanofiber or microfiber scaffolds. 
At the 6-week time point, there were no significant differences in cell number between any of the 
groups. 
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 Figure 13. DNA quantification on microfiber and nanofiber scaffolds with 
BMSCs and ADSCs after 3 & 6 weeks of chondrogenic differentiation 
Picogreen assay for DNA quantification at (A) 3 weeks, and (B) 6 weeks. 
Statistical significance between groups is indicated by matching symbols 
*,#,a,p<0.05, n=6. 
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After 3 weeks of culture, no significant differences between fiber types were found in 
GAG and collagen deposition, either total or on a per cell basis, for a given cell type (Figure 14). 
However, BMSCs on both microfibers and nanofibers secreted significantly higher amounts of 
GAG and GAG per DNA. BMSCs seeded on microfibers had higher total collagen content than 
ADSCs on either microfibers or nanofibers; however, when normalized to DNA, these 
differences disappeared. 
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Figure 14. GAG and collagen quantification on microfiber and nanofiber 
scaffolds with BMSCs and ADSCs at 3 weeks 
(A) GAG/scaffold; (B) Collagen/scaffold; (C) GAG/DNA; (D) Collagen/DNA  
Statistical significance between groups is indicated by matching symbols 
*,#,a,bp<0.05, n=6. 
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At week 6, the total amount of GAG and collagen deposited was higher in microfibers 
than nanofibers for both BMSCs and ADSCs (Figure 15). When GAG and collagen were 
normalized to the DNA content, microfibers still had higher amounts of deposition in 
comparison to nanofibers within each cell group as before, however there were not significant 
differences between deposition by BMSCs and ADSCs when seeded on the same fiber diameter.  
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Figure 15. Chondrogenic biochemical characterization on microfiber and 
nanofiber scaffolds with BMSCs and ADSCs at 6 weeks 
(A) GAG/scaffold; (B) Collagen/scaffold; (C) GAG/DNA; (D) Collagen/DNA  
Statistical significance between groups is indicated by matching symbols 
*,#,a,b,cp<0.05, n=6. 
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3.2.5 Biochemical characterization of osteogenesis. 
At week 3, there were no differences in cell number between any of the groups cultured in 
osteogenic medium. Alkaline phosphatase activity and calcium content were significantly higher 
on microfibers seeded with ADSCs than BMSCs seeded on either microfibers or nanofibers. 
When measured at 6 weeks, a significantly higher number of cells were found in BMSC-seeded 
than ADSC-seeded scaffolds for both fiber diameters. The number of cells found on ADSCs 
cultured on nanofibers was significantly lower than all other groups. ALP activity and calcium 
content had a similar pattern among groups at 6 weeks, with significantly more ALP activity on 
microfibers seeded with ADSCs in comparison to the other groups.  
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 Figure 16. Osteogenic biochemical characterization on microfiber and 
nanofiber scaffolds with BMSCs and ADSCs at 3 and 6 weeks 
(A,B) DNA, (C,D) Alkaline phosphatase activity, (E.F) Calcium content. At 3 
weeks (A,C,E) and 6 weeks (B,D,F). Statistical significance between groups is 
indicated by matching symbols *,#,a,bp<0.05, n=6. 
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3.2.6 Confocal immunofluorescence analysis of chondrogenesis 
Scaffolds cultured under chondrogenic conditions for 6 weeks all stained positively for collagens 
type I and type II, though the organization and quantity varied (Figure 17). Qualitative 
differences between the collagen labeled on the scaffold were not apparent when seeded with 
BMSCs, with a dense layer of both collagen types I and II on the surface of the scaffolds. 
However, ADSCs appeared to have a less smooth or organized pattern of collagen type I 
deposition and stained much less strongly for collagen type II than scaffolds seeded with 
BMSCs. Additionally, the density of cells seen per area was greater on the surface of nanofibers 
than microfibers.  
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Figure 17. Confocal immunofluorescence staining for collagen type I and 
type II in chondrogenic cultures with BMSCs and ADSCs after 6 weeks 
Collagen type I (green) staining of BMSCs on (A) nanofibers and (B) microfibers, 
and ADSCs on (E) nanofibers and (G) microfibers. Collagen type II (red) staining 
of BMSCs on (B) nanofibers and (D) microfibers, and ADSCs on (F) nanofibers 
and (H) microfibers. Nuclei stained with DAPI (blue). Images taken at 20x 
magnification, scale bar = 100 µm. 
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3.2.7 Confocal immunofluorescence analysis of osteogenesis 
All groups showed positive staining for each of the osteogenic marker proteins collagen type I, 
osteonectin, and osteocalcin (Figure 18). ADSCs seemed to lay down a thicker collagen network 
than BMSCs on both microfibers and nanofibers resulting in a smooth appearance on the surface 
of the scaffold, while the contours of the fibers could be seen on scaffolds seeded with BMSCs. 
Staining for both osteonectin and osteocalcin appeared to be more dense on nanofibers than 
microfibers for a given volume at the surface of the scaffold, but the overall pattern appeared to 
be similar.   
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Figure 18. Confocal immunofluorescence staining for collagen type I, 
osteonectin, and osteocalcin in osteogenic cultures with BMSCs and ADSCs 
after 6 weeks 
Collagen type I (A,B,C,D; green), osteonectin (E,F,G,H; green), and osteocalcin 
(I,J,K,L; red). Images taken at 20x magnification, scale bar = 100 µm. 
 
 
 
 
 
 
 
 
 
  76 
3.3 DISCUSSION 
The results of this study suggest that BMSCs and ADSCs have different potential for cartilage 
and bone regeneration when seeded on electrospun PCL scaffolds, and that the effects of fiber 
diameter are dependent on whether cells are cultured under chondrogenic or osteogenic 
conditions. 
Chondrogenic differentiation of MSCs was enhanced when cells were seeded on 
microfibers in comparison to nanofibers, and with BMSCs in comparison to ADSCs. Increased 
chondrogenesis of ADSCs and BMSCs seeded onto microfibers is in agreement with the results 
from experiments described in Chapter 2. A high initial seeding density in conjunction with the 
larger pores of the microfibers likely promoted mesenchymal condensation and formation of the 
cell-cell contracts important for chondrogenesis.  
Increased gene expression of COL2 and ACAN in cells seeded on microfibers and 
BMSCs after both 3 and 6 weeks of culture suggests that cells under these conditions are 
developing a more chondrogenic phenotype. At the 3-week time point, COL1 expression was 
higher with microfibers and BMSCs, while this pattern reversed at the 6-week time point. While 
COL1 expression is typically indicative of a fibrocartilagenous phenotype and therefore 
undesirable in articular cartilage tissue engineering, this increased level of expression early in 
culture may be indicative of undifferentiated MSCs more actively laying down a matrix to which 
they can attach prior to undergoing condensation and chondrogenic differentiation, and then 
remodel as the cells mature into chondrocytes.  
The differences in gene expression under chondrogenic differentiation conditions were 
also reflected in GAG and collagen deposition over the 6-week period. While at 3 weeks there 
were no differences in the amount of GAG or collagen on fibers with different diameters seeded 
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with the same cell type, by 6 weeks, cells seeded on microfibers had deposited more of these 
proteins than cells on nanofibers. Additionally, constructs seeded with BMSCs contained more 
GAG and collagen than those seeded with ADSCs. Staining for collagen types I and II further 
demonstrated the enhancement of chondrogenesis by BMSCs. All cultures stained strongly for 
collagen type I, while collagen type II staining was somewhat less intense on ADSCs seeded on 
microfibers, and quite limited on nanofibers. Additionally, constructs seeded with ADSCs had 
surface collagen staining that appeared fibrous, while constructs seeded with BMSCs resulted in 
collagen staining that appeared to be more smooth and dense, with potential evidence of lacuna-
like morphology similar to that seen in native cartilage. The inability to discern individual 
collagen fibers on BMSC constructs may be due to the collagen fibers becoming more finely 
divided while also becoming more densely packed, making it impossible to see individual fibers 
due to the resolution limits of confocal laser microscopy. Additionally, the appearance of the 
smooth collagen staining correlated strongly with the amount of GAG that was detected within 
the construct. An increasing amount of proteoglycan deposition may result in decreased size of 
the collagen fibers, as these matrix components interweave with each other. The presence of 
collagen type I staining suggests that the secreted matrix is not equivalent to that of the native 
cartilage, but it is possible that longer incubation times or implantation in vivo could lead to more 
significant matrix remodeling and a higher ratio of collagen type II in comparison to collagen 
type I.  
Addition of BMP-6 to chondrogenic medium has been shown to enhance chondrogenic 
differentiation of ADSCs, likely by inducing expression of the TGF-β-receptor-I protein required 
for response to TGF-β3.113,114 The combination of growth factors utilized in this study—10 
ng/ml each of TGF-β3 and BMP-6—was previously shown to induce chondrogenesis similar to 
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BMSCs cultured in TGF-β3 alone in pellet cultures.113 Similar results were found in our 
additional studies (see Appendix D). Compared to data presented in Chapter 2, where medium 
contained only TGF-β3 and not BMP-6, addition of BMP-6 increased DNA and GAG 
production by both BMSCs and ADSCs. Interestingly, the amount of collagen produced was 
actually lower with the addition of BMP-6, particularly on microfibers, but it is unclear whether 
the increase is due to an increase in collagen type I or type II since all samples stained strongly 
for both types of collagen and no quantitative analysis, such as ELISA, was performed. ADSCs 
seeded on microfibers cultured in TGF-β3 and BMP-6 appeared to be somewhat in-between the 
two BMSC groups, with areas that had fibrous-appearing staining, and others where the density 
appeared to be higher.  
While BMP-6 has been shown to induce chondrogenesis of ADSCs in vitro, it is 
expressed by hypertrophic chondrocytes and can induce endochondral ossification in vivo.124 
Studies investigating the use of BMP-6 for chondrogenesis of ADSCs are somewhat 
inconclusive, with some studies suggesting that BMP-6 increases the expression of COL10, a 
marker of chondrocyte hypertrophy, while others show strict down-regulation.113,114,116 
Therefore, evaluating the expression of hypertrophic and osteogenic genes and proteins in 
addition to the chondrogenic studies already performed may be useful for determining whether 
cells are halting differentiation when they become mature chondrocytes, or if they are continuing 
on towards bone formation.   
While clear dependence on both fiber diameter and MSC tissue source was found when 
culturing constructs under chondrogenic conditions, a slightly different pattern was found when 
cells were cultured under osteogenic conditions. At both 3 and 6 weeks of culture, ALP activity 
and calcium deposition were higher in microfiber constructs seeded with ADSCs, while no 
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differences were found with different fiber diameters when seeded with BMSCs. This suggests 
that while BMSC differentiation is not sensitive to fiber diameter, ADSC differentiation appears 
to be, with microfibers promoting osteogenesis more than nanofibers. Gene expression changes 
also provide some evidence of enhanced osteogenic differentiation in ADSCs, particularly on 
microfibers. COL1 expression is increased in ADSCs at 3 weeks of culture, while ON and OC 
are upregulated after 6 weeks. COL1 expression is considered an early marker of osteogenesis as 
collagen deposition eventually leads cells to slow their proliferation and begin to undergo 
differentiation.125 Osteonectin (ON) is a commonly used marker for developing osteoblasts and 
is thought to play a role in initiation of mineralization126, while osteocalcin (OC) is  a marker of 
fully differentiated osteoblasts.127 Thus, the increase of ON in ADSCs at 6 weeks is indicative of 
ongoing osteoblastic differentiation and beginning mineralization. ADSCs seeded on microfibers 
have a much higher level of OC expression than on nanofibers, while ON is slightly lower. This 
may indicate that more cells in the microfiber group have become fully differentiated osteoblasts 
or even early osteocytes, though high levels of ALP expression suggest that many cells may still 
be actively undergoing the differentiation process. Visualization of osteogenic proteins by 
immunofluorescence showed increased organization and density of collagen fiber deposition by 
ADSCs, while differences in osteonectin and osteocalcin were more difficult to detect, though it 
appeared that the density of staining may be greater on nanofibers in comparison to microfibers. 
This might be explained by different cell penetration depth into the scaffold, with cells migrating 
and depositing matrix throughout the scaffold when seeded on microfibers, while matrix 
formation only occurred near the surface for nanofibers since the small pores of the nanofibers 
inhibit cell migration beyond the scaffold surface.  
  80 
Previous studies have examined the effects of fiber diameter on osteogenesis in immature 
osteoblasts as well as BMSCs, with results suggesting that either fiber diameter had no effect on 
or that larger fiber diameters enhance osteogenesis.128–132 One study examined osteogenesis of 
BMSCs on polyethylene terephthalate fibers between 2 and 42 µm in diameter, concluding that 
microfibers between 9 and 12 µm in diameter most effectively promoted osteogenesis of 
BMSCs, by increasing ALP activity and osteocalcin synthesis.128 Another study seeded 
osteoprogenitor cells onto PLLA scaffolds with either 140 nm or 2.1 µm fiber diameters, and 
saw no differences in ALP activity between groups, though larger fibers promoted increased cell 
proliferation.129 These findings are supported by the results in our study that showed modest 
increases in gene expression of ON and OC by BMSCs seeded on microfibers, with no 
significant differences in ALP activity, calcium deposition, or staining for osteonectin and 
osteocalcin. Interestingly, ADSCs seemed to be more affected by the fiber diameter, with 
enhanced osteogenesis occurring on microfibers. This is in contrast to many studies that have 
indicated that ADSCs have reduced osteogenic potential in comparison to BMSCs. However, 
these previous studies were all performed in monolayer cultures, suggesting that 3D culture 
conditions may be a more effective method for evaluating differentiation potential of cells for 
tissue engineering applications.  
It should be noted that the BMSCs and ADSCs used in this study were not isolated from 
the same patient. Donor variability is common, making it difficult to conclude that MSCs derived 
from one tissue will always be more effective than another. The cells in this study were chosen 
based on matching of the age and sex of the donors as well as qualitative differentiation potential 
in monolayer. Additionally, cells from multiple donors were pooled in order to obtain a more 
generalized perspective on how cell source might affect differentiation. When moving towards 
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clinical application, an individualized approach where direct comparisons between MSCs 
isolated from different tissues from a single patient are performed may be warranted; however, if 
expanded studies show consistency in outcomes, this may be unnecessary.  
3.4 CONCLUSION 
BMSCs constitute only 0.001 to 0.01% of the total cells isolated from bone marrow, with 
numbers also decreasing with increasing age. Thus, in vitro expansion is likely necessary prior to 
use of cells in tissue engineering applications since only very limited volumes of bone marrow 
can be safely and effectively obtained and large numbers of cells are likely required.133 In 
comparison, much larger quantities of adipose tissue are more easily obtained with less 
associated pain and risk to the donor, reducing the time needed to obtain a sufficient quantity of 
cells and avoiding potential changes in cell phenotype caused by extended in vitro culture. 
Therefore, when choosing a cell source, it is important to consider not only the differences in 
differentiation potential but also risks incurred in order to provide treatment. Additionally, the 
differences in cell differentiation potential seen during in vitro culture may not translate in vivo, 
and further optimization of culture conditions could likely enhance both ADSC and BMSC 
chondrogenic and osteogenic differentiation.  
While there have been a number of studies comparing the chondrogenic or osteogenic 
potential of BMSCs and ADSCs, to our knowledge, this is the first comparing the differentiation 
of these cell types on electrospun fibers as well as evaluate the effects of fiber diameter on 
ADSC behavior. Under the specific culture conditions utilized, the important findings of this 
study are summarized as follows: (1) PCL microfibers provide a better substrate than nanofibers 
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for chondrogenesis; (2) BMSCs have increased chondrogenic potential on PCL fibers in 
comparison to ADSCs using medium containing TGF-β3 and BMP6; (3) Fiber diameter does not 
influence osteogenesis of BMSCs; and, (4) ADSCs have improved osteogenic potential on 
microfibers in comparison to nanofibers. 
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4.0  SEQUENTIAL SEEDING STRATEGIES INFLUENCE OSTEOGENESIS IN CO-
CULTURES OF MESENCHYMAL STEM CELLS AND ENDOTHELIAL CELLS 
4.0 INTRODUCTION 
Co-culture of MSCs with endothelial cells (ECs) has been shown to cause increased MSC 
secretion of VEGF leading to increased BMP2 production by endothelial cells, and enhanced 
MSC osteogenesis as a result.79 Many studies have examined the potential benefits of co-
culturing endothelial cells (ECs) with MSCs in 3D scaffolds for bone tissue engineering with 
promising results. Most of these studies were performed using hydrogel scaffolds, which have 
limited potential for bone tissue engineering due to a lack of sufficient mechanical properties. 
Only one previously published study with 3D co-culture of ECs and MSCs has used electrospun 
scaffolds.134 In this study, MSCs and umbilical vein ECs were seeded onto electrospun PCL 
scaffolds with a 10 µm fiber diameter and cultured for 7-14 days in osteogenic medium. The co-
cultured scaffolds had higher levels of alkaline phosphatase (ALP) activity and calcium 
production than constructs seeded with MSCs alone, although this effect was decreased when 
scaffolds were cultured in a flow perfusion bioreactor in comparison to static culture. These 
findings suggest that electrospun scaffolds should be further investigated for use in co-culture 
studies where both osteogenesis and angiogenesis is essential.   
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While most co-cultures on scaffolds are typically initiated by simultaneously seeding ECs 
and osteogenic cells at the chosen cell density and ratio, there are a few studies examining the 
effects of sequential seeding where one cell type is seeded onto the scaffold prior to the other. 
Seeding ECs onto collagen-GAG scaffolds three days prior to seeding MSCs resulted in 
enhanced formation of vessel-like structures in vitro and increased vascularization in vivo.135 
However, MSCs were not induced to undergo osteogenesis, leaving the effects that these co-
culture conditions have on bone formation unclear. Another study utilized a sequential seeding 
protocol where endothelial progenitor cells were seeded onto PCL-hydroxyapatite scaffolds three 
days prior to seeding of osteoblasts.136 Capillary density in vivo increased in the co-culture group 
in comparison to endothelial progenitor cells alone on scaffolds, along with increased 
osteogenesis and decreased necrosis of the tissue within the scaffold in comparison to cultures 
with osteoblasts only. Unfortunately, there was not a group where the two cell types were seeded 
at the same time, and thus the effects of sequential seeding in comparison to co-seeding could 
not be evaluated.  
Other studies have taken the opposite approach, pre-seeding primary osteoblasts (pOBs) 
or MSCs prior to addition of ECs. Silk scaffolds seeded with pOBs one day prior to the addition 
of ECs formed more blood vessels and had higher osteogenic gene and protein expression in 
comparison to monocultured pOBs in vitro.137 Another group investigated the effects of seeding 
MSCs onto porous PLGA scaffolds under osteogenic conditions for one week followed by 
addition of HUVECs.138 Greater vessel formation was observed in vivo with MSC co-culture 
than when ECs were cultured alone.  
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While the benefits of co-culture seem clear regardless of the choice of the sequence of 
cell seeding, a controlled direct comparison evaluating vascularization and osteogenesis with 
sequential or concurrent seeding of osteogenic cells and ECs has not been conducted. In this 
study we performed co-culture experiments seeding MSCs and human dermal microvascular 
endothelial cells on microfiber PCL scaffolds seeded either at the same time or sequentially with 
three days between the seeding of each cell type to determine whether this strategy can lead to 
improvements in the development of a functional tissue engineered bone replacement. 
4.1 METHODS 
4.1.1 Electrospinning and scaffold characterization 
Microfiber scaffolds were electrospun using the same parameters and characterized as previously 
described in Sections 2.2.1 and 3.2.1. SEM was performed and scaffold fiber diameter and pore 
size were determined using the automated algorithm described above. 
4.1.2 Cell culture and seeding 
MSCs were isolated from bone marrow and cultured as described in Sections 2.2.2 and 3.2.2. 
Passage 5 cells were utilized in this study. The human dermal microvascular cell line, HMEC-1 
(US Center for Disease Control and Prevention, Atlanta, GA) was maintained in endothelial 
growth medium (EGM-2 BulletKit; Lonza, Walkersville, MD) and expanded to Passage 9.  
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The day prior to seeding, scaffolds were cut into 0.8mm disks, hydrated with 70% 
ethanol for 2 hours, rinsed with PBS, and soaked overnight in growth medium. Five different 
seeding conditions were utilized, with the individual groups detailed in Table 2. Cells were 
trypsinized, counted, and resuspended at a concentration of 6.7x106 cells/ml. 15 µl (2x106 
cells/cm3-scaffold) of the cell suspension was then seeded onto the surface of the scaffold and 
cells were allowed to attach, with addition of 10 µl of medium after 1 hour to prevent drying, 
followed by addition of 2 ml of medium after 2 hours. Between Phase I and Phase II seeding, 
constructs were maintained in cell-specific growth medium (Appendix A) After culturing the 
constructs for 3 days, Phase II of seeding was performed in the same manner as Phase I.  
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Table 2. Groups for sequential seeding experiment 
 
Group 
# 
Phase I  
(cells/cm3-scaffold) 
Phase II 
(cells/cm3-scaffold) 
Culture Medium Prior 
to Differentiation 
1 ECs  
(2x106) 
MSCs  
(2x106) 
EGMa 
2 MSCs  
(2x106) 
ECs  
(2x106) 
MGMb 
3 
- 
ECs & MSCs 
(2x106 each) 
1:1 
EGM:MGM 
4 
- 
MSCs  
(4x106) 
MGM 
5 
- 
ECs  
(4x106) 
EGM 
aEndothelial growth medium         bMSC growth medium 
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4.1.3 Osteogenic differentiation 
24 hours after Phase II seeding, the culture medium was switched from growth to 
osteogenic medium to induce differentiation. Medium was changed every 2-3 days and 
constructs were analyzed after 7, 14, and 21 days of differentiation. Figure 19 summarizes the 
experimental timeline for this experiment. 
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Figure 19. Experimental timeline for sequential seeding study 
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4.1.4 RNA Isolation and qPCR 
RNA was isolated, reverse transcribed, and then amplified using qPCR, as described in Section 
2.2.4, to determine relative gene expression. The genes examined were COL1, ON, OC, 
RUNX2, alkaline phosphatase, osteopontin, VEGF and angiopoeitin-1. Sequences of primers and 
conditions used for qPCR can be found in Appendix B.  
Since reverse transcription was performed using the same amount of RNA for each 
sample, without normalization the relative gene expression by MSCs for Groups 1-3 that contain 
both MSCs and ECs would be skewed negatively since these groups have fewer MSCs than 
Group 4. Therefore, we normalized the data by weighting to the number of MSCs initially 
seeded onto the scaffolds (i.e. Group 4 expression was divided by 2).  
4.1.5 Assays for osteogenesis 
Osteogenic assays for quantification of total DNA, ALP activity, and calcium content were 
performed as described in section 3.2.7. For ALP activity and calcium content, the values were 
normalized to the number of MSCs originally seeded on the scaffolds in order to account for 
differences between co-culture groups and Group 4. 
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4.1.6  Enzyme-linked immunosorbance assay (ELISA) 
The culture medium was collected at 7, 14, and 21 days, centrifuged at 2,000 rpm and 4°C for 10 
minutes to remove cell debris, and frozen at -80°C until the assay was performed. The quantity 
of VEGF secreted by the cells into the media was analyzed using an ELISA kit (R&D systems) 
according to the manufacturers instructions. 
4.1.7 Immunofluorescence  
Constructs were fixed for 20 minutes in 4% PFA and stained using methods described in section 
3.2.8. Samples were permeabilization in PBS containing 0.1% Triton-X 100 for 10 minutes, 
followed by blocking in 5% goat serum. Primary antibodies for collagen type I, osteocalcin, 
osteonectin and osteopontin were applied to constructs, and kept at 4°C overnight. Secondary 
antibodies were applied for 1 hour at room temperature to detect primary antibodies, followed by 
staining with DAPI to detect nuclei. Samples were examined using laser confocal scanning 
microscopy and images were processed and analyzed with NIS Elements software. 
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4.2 RESULTS 
4.2.1 Scaffold characterization 
Electropsun PCL microfiber scaffolds had a diameter of 4.63 ± 0.76 µm, an overall porosity of 
90%, and an average pore size of 90 µm2. A representative SEM image of the scaffold is shown 
in Figure 20.  
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Figure 20. SEM image of microfibers 
Image taken at 500x. Scale bar = 10 µm 
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4.2.2 Gene expression 
Results of qPCR analysis for gene expression are shown in Figure 21. The results show lower 
expression in Group 4 for all genes examined except for osteocalcin and osteopontin. RUNX2 
expression was relatively stable overall, but was slightly higher in Group 3 at day 7 and 14, 
decreasing to a level similar to Groups 1 and 2 at day 21. ALP expression was similar at day 7 
for Groups 1 and 2 and remained relatively stable at days 14 and 21, while it was higher at day 7 
in Group 3 and then decreased at the later time points. COL1 expression was similar for all co-
cultured groups and decreased from day 7 to day 21. Osteopontin expression increased in all 
groups between day 14 and 21, and was highest in Groups 1 and 4. Osteonectin expression 
increased similarly for all co-culture groups over the culture period. Osteocalcin expression was 
stable in Group 3 across all time points, while expression decreased from day 7 to day 14 in both 
Groups 1 and 2. At day 21, osteocalcin expression increased to day 7 levels for Group 2, while 
not changing in Group 1. VEGF expression sharply increased from day 7 to day 21 in Group 2, 
while in Groups 1 and 3 the increase was more moderate. ANG1 expression was similar for 
Groups 1 through 3.  
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Figure 21. Gene expression profiles in osteogenic MSC-EC co-cultures 
Gene expression for osteogenic differentiation at days 7, 14, and 21. Groups are 
normalized to the expression in the MSC-only group in addition to normalization 
for the initial MSCs seeded. Endothelial-only group expression is not shown since 
expression was quite low (CT values > 35).  
 
  96 
4.2.3 Biochemical content 
Results for cellularity, ALP activity and calcium deposition are presented in Figure 22. No 
significant differences in the DNA content as measured by the Picogreen assay were found 
between groups at day 7 or 14, while at day 21 Group 4 had significantly more cells than the 
other groups. ALP activity was similar for all groups at day 7; however, it decreased 
significantly in Group 4 at day 14 and 21, while Groups 1-3 had no significant differences 
between them. The calcium content was also not significantly different between groups at day 7; 
however, at day 14 and day 21, the calcium content of the cultures in Group 2 was significantly 
higher than in the other groups. Group 5, which contained only ECs had negligible ALP activity 
and calcium deposition at all time points, and was thus excluded from the analysis.  
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Figure 22. Biochemical characterization of scaffolds in MSC-EC osteogenic 
co-culture conditions 
(A) DNA content, (B) ALP activity, and (C) total calcium content. Values for 
Group 4 were divided by 2 to normalize number of cells. *p<0.05, n=3 
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4.2.4 VEGF secretion 
The quantity of VEGF released into the medium was measured using a standard ELISA kit. The 
amount of VEGF increased over time and was significantly higher for Groups 1-3 than Group 4. 
There were no significant differences at any of the time points between the co-culture groups 
(Figure 23).  
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Figure 23. VEGF secretion in MSC-EC co-cultures 
VEGF secretion by cells over a 72 hour period and measured at days 7, 14, and 
21. *p<0.05 indicates significantly different than all other groups at the time 
point, n=3. 
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4.2.5 Osteogenic matrix deposition 
Representative images for immunofluorescence staining of collagen type I, osteonectin, 
osteopontin and osteocalcin are shown in Figure 24. Collagen type I organization varied between 
groups. In Group 4, dense deposits of randomly oriented collagen fibers are seen, while in 
Groups 1 and 3, thin collagen fibers appeared to be mostly oriented along a single axis. In Group 
2, larger fiber bundles are apparent and appeared to be arranged in a web-like network 
interspersed with fine collagen fibers below.  
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Figure 24. Confocal immunofluorescence imaging for osteogenic markers in          
MSC-EC co-cultures 
Collagen type I (A,B,C,D; green), osteocalcin (E,F,G,H; red), osteonectin 
(I,J,K,L; green), and osteopontin (M,N,O,P; red). Images taken at 20x 
magnification, scale bar = 100 µm. 
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4.3 DISCUSSION 
Several previous studies have seeded MSCs and ECs sequentially in order to improve 
osteogenesis and/or angiogenesis.135–138 However, there have been no investigations into whether 
sequentially seeding cells is beneficial compared to simultaneous seeding or if seeding MSCs or 
ECs first results in better osteogenic differentiation of the co-culture. In this study, we have 
found that in co-culturing osteogenic cells with ECs, pre-seeding MSCs onto PCL scaffolds three 
days prior to endothelial cells significantly improves osteogenic differentiation in comparison to 
monoculture of MSCs or pre-seeding ECs prior to adding MSCs.  
RUNX2 is considered the master regulatory gene for differentiation of MSCs into 
osteoblasts, inducing the induction of gene expression of ALP, collagen type I, osteopontin and 
bone sialoprotin-2.139 Our results showed increased expression of RUNX2 as well as other 
markers of osteogenic differentiation in co-culture compared to MSC monoculture conditions, 
suggesting the presence of ECs at any time promoted enhanced osteogenic differentiation. In 
particular, ALP expression and activity were both increased with co-culture; however, no 
significant differences were found in ALP activity between any of the co-culture groups. ALP 
expression is typically turned on at the early stages of osteoblast differentiation, marking the 
shift from proliferation to differentiation and then plateaus or decreases at the onset of 
mineralization.125 The cell number in the monoculture group continued to increase through the 
21 day period, compared to more modest increases in the co-culture groups, suggesting that the 
presence of ECs may induce earlier differentiation of MSCs and may explain the unchanged 
ALP expression and activity levels at later time points.  
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Collagen type I is the main macromolecular component of bone, making up 90% of the 
protein matrix.  In this study, COL1 expression decreased over the culture period, which may be 
an indication that cells underwent a shift from a proliferative state to one of differentiation. 
Previous studies have shown that collagen matrix deposition actually induces differentiation, and 
that increased collagen deposition occurs in co-culture between endothelial cells and 
osteoprogenitors.125,140 Additionally, the reduced secretion of collagen type I may be associated 
with remodeling of the matrix during differentiation to form a more organized ECM structure. In 
this study, we saw differences in collagen organization with MSC-EC co-culture by means of  
immunostaining for collagen type I. While collagen fibers appeared to have random orientations 
in the MSC group in monoculture, co-culture with ECs resulted in a more aligned matrix with 
distinct fiber orientation. Moreover, in the group with MSCs seeded prior to ECs, collagen fibers 
on the surfaces appeared to be organized into cord-like structures. This feature suggest that ECs 
could be organizing into a pre-vascular-like network that may contribute to improved vessel 
formation in an in vivo environment.  
Non-collagenous proteins play an important role in osteogenic differentiation and bone 
formation. Osteonectin is used as a marker of osteogenic differentiation and is found after the 
initiation of mineralization, where it may play a role in controlling the growth and size of 
hydroxyapatite crystals. In our study, we see a gradual increase in osteonectin gene expression 
over the culture period that is not different between the co-cultured groups, and somewhat higher 
amounts of staining in Groups 1 and 2, although staining is seen in Groups 3 and 4 as well. It is 
likely that while osteonectin can be utilized as a marker for the onset of osteogenesis, that the 
levels at which it is expressed or produced are weak indicators of functional outcomes, 
particularly since it may not play an important role during early bone formation and has also 
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been shown to be expressed in endothelial cells during angiogenesis.141 The role of osteopontin 
during bone formation is somewhat unclear; however it strongly binds to calcium and is known 
to function during the initiation of mineralization, and it has been hypothesized that it may play a 
role in regulating crystal formation.142 Osteopontin has been found to be expressed during the 
proliferative stages of osteogenesis, then down regulated during early differentiation, and then 
increased again at the beginning of mineralization. Results in this study follow a similar pattern, 
where there is a decrease in osteopontin expression between days 7 and 14, followed by a 
significant increase at day 21. Osteocalcin is considered a late marker of osteogenic 
differentiation and similar to osteonectin is not active at the site of crystal initiation, but is 
thought to play a later role in regulating crystal growth.142 Unlike other markers examined, 
osteocalcin expression was higher in the monoculture group and did not increase in co-culture 
groups over time, suggesting that the presence of ECs inhibited its expression. However, 
previous studies have shown that changes in osteocalcin gene expression may not necessarily 
correlate with differentiation potential.143–145 
In this study, gene expression of traditional markers of bone differentiation such as 
RUNX2, ALP osteopontin, osteonectin and osteocalcin were not useful for distinguishing 
differences in cell behavior between groups since there was little difference between each of the 
three co-culture conditions. However, significantly greater calcium deposition within the Group 
2 constructs, onto which MSCs were seeded 3 days prior to ECs, suggests that there is an 
interactive process between MSCs and ECs that is stimulating enhanced mineralization in this 
group compared to the other co-cultures. MSC-EC interactions have been shown to occur both 
through growth factor and cytokine release, as well as by direct contact between cells via cell-
cell junctions.140,146–148 Soluble factors, including fibroblast growth factors (FGFs), bone 
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morphogenetic protein (BMPs), insulin-like growth factors (IGFs), platelet derived growth factor 
(PDGF) and VEGF, have all been shown to play a role in both mesenchymal osteogenic 
differentiation and bone formation during either development or healing. 
VEGF is an important mediator between osteogenesis and angiogenesis, acting both in a 
paracrine and autocrine manner.149 VEGF produced by hypertrophic chondrocytes in the 
developing bone is a chemotactic factor that attracts ECs from the surrounding vasculature, 
promoting the expression of matrix-degrading enzymes to allow for capillary invasion into the 
calcified cartilage matrix. This action leads to recruitment of osteoclasts from the vasculature as 
well as induces osteoprogenitor differentiation, resulting in remodeling of the matrix into 
mineralized bone. Blocking VEGF action in vivo using a soluble chimeric receptor protein 
prevents vascular invasion and bone formation, both during development as well as during bone 
repair.150,151 VEGF is also important for intramembranous bone formation, which is similar to the 
mesenchymal osteogenic differentiation process by MSCs observed in vitro. In this process, 
mesenchymal cells differentiate directly into bone without a cartilage intermediate, enhancing 
both neovascularization as well as inducing ECs to secrete growth factors and cytokines that 
promote osteogenic differentiation.153 Inhibition of VEGF using the same soluble blocking 
protein as described above in a mouse cortical tibia defect resulted in delayed turnover of the 
hematoma and slowed maturation of the bone from a woven to a lamellar bone. Previous studies 
have shown that VEGF is typically expressed at low levels until the onset of mineralization, 
where it increases significantly.154 In this study, VEGF gene expression was upregulated at day 
21 in Group 2 compared to both of the other two co-culture groups and Group 1 with only 
MSCs. VEGF secretion into the medium as measured by ELISA was not significantly different 
between the co-culture groups, although the values were significantly higher than the 
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monoculture group and continued to increase over the 21 day period. These results suggest that 
direct co-cultures with ECs increases VEGF secretion by MSCs, leading to increased 
osteogenesis. However, the 5 to 7 times higher amount of calcium in Group 2 compared to the 
others in conjunction with no differences in VEGF suggests that there are likely other 
mechanisms contributing to the increased calcium accumulation when MSCs are seeded onto 
PCL scaffolds 3 days prior to ECs. It is possible that VEGF is not released into the medium, but 
instead is sequestered within the matrix. Further investigations into the location of VEGF or 
other angiogenic growth factors within the construct would be valuable. 
One potential explanation for the increased mineralization seen in Group 2 could be that 
seeding MSCs first established the formation of cell-cell contacts, collagen matrix deposition, 
and secretion of growth factors prior to the addition of ECs. This is similar to intramembranous 
ossification, where MSCs undergo condensation and then begin differentiation to osteoblasts 
prior to the invasion of endothelial cells. While we initially considered that seeding ECs first 
would allow them to establish a pre-vascular network prior to the addition of MSCs and 
therefore enhance future vessel formation throughout the tissue, the vast difference in 
mineralization suggests that might not be the optimal strategy. The mechanisms underlying the 
enhanced differentiation of MSCs when seeded prior to ECs may be explained by the positive 
feedback loop that has previously been shown to occur between MSCs and ECs when they are 
seeded in direct culture. MSCs have been shown to express and secret growth factors such as 
VEGF and EGFL6 that enhance recruitment of ECs and promote angiogenesis.151,155,156 Once 
recruited, ECs then secrete growth factors that enhance osteogenesis, such as BMPs and 
endothelin-1, thereby leading to improved bone as well as vessel formation.156–158 By seeding 
MSCs prior to ECs in the manner described in this study, MSCs may have produced angiogenic 
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factors that enhanced attachment of ECs and their subsequent secretion of osteogenic factors. 
Future investigation into the the kinetic profile of expression and production of these growth 
factors may lead to better understanding of the mechanisms that resulted in the enhanced 
osteogenesis seen when MSCs were seeded before ECs.  
 Additional investigation into the differences in the organization of the collagen fiber 
network and how it may affect mineralization could provide further insight into the mechanism 
of enhanced mineralization in Group 2. The disorganized arrangement of collagen fibers in 
woven bone results in reduced crystal size and lack of orientation of deposited mineral. Collagen 
fibers were more organized in Group 2, resembling the organization in lamellar bone, and least 
organized in Group 4, where they appeared to be more like woven bone. Groups 1 and 3 had 
collagen matrices that were somewhat aligned, but did not appear as robust as Group 2. 
4.4 CONCLUSION 
Development of a functional tissue engineered bone construct for implantation will require that it 
be vascularized, either before or soon after implantation in order to avoid necrosis. Co-culture of 
ECs with MSCs or osteoprogenitors is an attractive approach since these two cell types are 
naturally coupled in vivo and may enhance each other’s activities and function. In this study, we 
have examined the effects of pre-seeding either MSCs or ECs in comparison to seeding both cell 
types at the same time, or maintaining cells in monoculture. It was clear that co-culture greatly 
enhanced osteogenesis regardless of seeding approach. Additionally, seeding MSCs for 3 days 
prior to seeding ECs generated a much higher amount of calcium per construct than any other 
group. Interestingly, gene expression for osteogenic markers, ALP activity, VEGF production 
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and proliferation were not significantly different from the other co-culture groups, suggesting 
that the reason for the apparent enhancement of osteogenic differentiation is at least in part due 
to yet to be defined mechanisms. One hypothesis is that seeding MSCs prior to ECs closely 
resembles the developmental process of intramembranous ossification, with establishment of 
cell-cell communications between MSCs, a basic collagen network, and secretion of growth 
factors which recruit ECs and initiate a positive feedback loop that enhances osteogenic 
diffrentiation. More refined examination of the collagen matrix architecture as well as inspection 
of the interactions occurring between cells and growth factor production may be useful in order 
to understand the benefits of pre-seeding of MSCs.  
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5.0  SUMMARY AND FUTURE DIRECTIONS 
Current methods for treating bone and cartilage defects are severely limited in their 
effectiveness. Successful development of functional tissue engineered replacements has the 
potential to greatly reduce the morbidity and long-term economic burden associated with treating 
patients suffering from skeletal diseases. Combining stem cells with scaffolds that mimic the 
native tissue structure and applying stimuli, both mechanical and/or biochemical, researchers aim 
to create new tissues de novo that can be successfully integrated with the patient’s body and 
restore original structure and function. In this work, we have focused on obtaining further 
understanding of the complex interactions that occur between cells and materials to improve 
future tissue engineering designs for bone and cartilage.  
In the first aim of this thesis, we evaluated the chondrogenic differentiation of MSCs 
seeded at different initial cell densities onto microfiber (~4 µm) and nanofiber (~400 nm) 
scaffolds. We found that in order to stimulate chondrogenesis a minimum seeding density of 
500,000 cells/cm3-scaffold should be used, as lower seeding densities resulted in significantly 
reduced chondrogenic gene expression and minimal ECM production. Utilizing seeding densities 
up to 4,000,000 cells/cm3-scaffold resulted in increased deposition of GAG and collagen. 
Additionally, microfibers were more effective than nanofibers at inducing chondrogenesis. We 
suspect that the mechanism driving enhanced chondrogenesis using microfibers and high cell 
seeding densities is multifactorial, and is likely related to the small pore size in nanofiber 
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scaffolds. Microfibers have an average pore size of 91 µm2 while nanofibers have a pore size of 
2.1 µm2. This property limits cells to the superficial areas of the nanofiber scaffolds, therefore 
reducing the total surface area available for tissue formation. Additionally, the high fiber density 
per area on the surface of the scaffolds likely causes cells to interact with scaffolds instead of 
inducing the cell-cell interactions that are required to initiate chondrogenic differentiation. 
Conversely, the larger pores of microfibers allow cells to penetrate throughout the thickness of 
the scaffold as well as support cell-cell interactions as the cells can form clusters in the spaces 
between fibers. In native cartilage, the largest collagen fibers are similar in diameter to the 
nanofibers we used in our experiment, and most are much smaller. Therefore, at first glance, our 
results may appear to go against the widely applied view that closely mimicking the native tissue 
ECM is the optimal tissue engineering approach. However, in native cartilage, cells encase 
themselves within a nanofibrous matrix that is endogenously produced rather than being placed 
on top and having to migrate through a pre-formed matrix. Therefore, a more accurate approach 
to compare the effectiveness of nanofibers versus microfibers for cartilage tissue engineering 
would be to develop a nanofiber scaffold with similar pore size as the microfiber scaffold. This 
would eliminate the confounding variable of cells being trapped on the surface of the nanofiber 
scaffold, and would allow for a more equivalent comparison regarding cell-cell and cell-matrix 
interactions. Additionally, cell distribution into the scaffold would likely be more homogeneous 
by seeding and/or culturing cells under dynamic conditions such as in a perfusion bioreactor or 
spinner flask. This would maximize the area for tissue formation within the scaffold as well as 
equalize it to provide the most accurate comparison. While there were some limitations in the 
study design presented here due to the small pore size of nanofiber scaffolds, the importance of 
high cell seeding densities as well as ensuring that scaffolds promote cell-cell adhesions are 
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important factors that should be taken into account in experimental designs aimed at optimizing 
parameters for specific tissue engineering application. For instance, utilizing a low cell density 
(<500,000 cells/cm3) to examine chondrogenesis on any fiber type may provide inaccurate 
information since it is unlikely that chondrogenesis will be sufficiently induced to provide an apt 
comparison between conditions, and particularly low values could end up being skewed during 
normalization.  
In the second aim of this thesis, we examined the effect of fiber diameter and MSC tissue 
origin on both chondrogenesis and osteogenesis. Adipose-derived stem cells (ADSCs) are an 
attractive source of MSCs since they can be isolated in larger quantities with less invasive 
procedures than bone marrow-derived MSCs (BMSCs). Similar to the previous study, 
chondrogenesis was enhanced on microfibers in comparison to nanofibers, regardless of cell 
source. In this experiment, BMP-6 was added in addition to TGF-β3, since this combination has 
been shown to be required to optimize the chondrogenic differentiation of ADSCs.114 This 
treatment enhanced GAG and reduced collagen deposition in comparison to chondrogenic media 
with TGF-β3 only. It is noteworthy that despite the addition of BMP-6, the chondrogenic 
potential of ADSCs was lower than BMSCs. Osteogenic differentiation was not as sensitive to 
changes in fiber diameter, with only ADSCs seeded on microfibers showing significantly higher 
ALP activity, calcium deposition and more organized collagen matrix deposition. These findings 
demonstrate that it is important to optimize culture conditions for each tissue source and for each 
cell type. In this study, we have used several cell populations that were matched by age and sex 
and pooled for the experiments presented here. Future experiments utilizing cells isolated from 
the same patients should be performed in order to determine if the patterns remain consistent 
across an extended population. Additionally, as in the first study it may be useful to seed and 
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culture cells under dynamic conditions to improve cell distribution throughout the scaffolds. 
Overall, the results of the first two studies suggest that scaffold fiber diameter plays a role in cell 
differentiation, particularly for chondrogenesis, and that while ADSCs are a promising cell 
source for tissue engineering of bone and cartilage, further optimization of both media 
components as well as scaffold architecture would be helpful. 
In addition to the evaluation of the scaffold architecture’s role in differentiation, the final 
study reported here was to determine if sequential seeding of MSCs and ECs was able to enhance 
osteogenic differentiation, perhaps via the establishment of a rudimentary vascular network that 
can anastamose with the host vasculature.  Ideally, such an approach would minimize or prevent 
necrosis of the engineered tissue upon implantation in vivo. All co-culture conditions resulted in 
increased osteogenic gene expression and ALP activity in comparison to monoculture, 
suggesting that regardless of the seeding method, addition of ECs had a positive impact on the 
osteogenic differentiation of MSCs. Interestingly, seeding MSCs three days prior to ECs 
increased mineralization in the scaffold in comparison to seeding ECs before MSCs or seeding 
both cell types at the same time. This may have been in part due to an increase in MSC secretion 
of VEGF, which can enhance osteogenic differentiation via autocrine or paracrine effects. 
Another mechanism that may have led to increased osteogenesis by pre-seeding MSCs may be 
the establishment of requisite cell-cell interactions and deposition of a rudimentary collagenous 
matrix that help prime MSCs for differentiation prior to addition of ECs, similar to the sequential 
cellular processes that occur during endochondral bone formation. Future investigations to 
identify potential signaling molecules from MSCs and/or ECs that may act to induce increased 
mineralization as well as to explore the interactions between cells may be useful to decipher the 
mechanisms that can lead to development of a functional tissue engineered construct.  
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In conclusion, each component of a tissue engineering strategy—cells, scaffolds, and 
bioactive factors—plays an essential role in the de novo creation of a new tissue, and each of 
these components may influence the effects of another, often making it difficult to compare 
between different studies. In the experiments above, we showed that several different culture 
parameters including cell seeding density, cell source, scaffold fiber diameter, timing of cell 
seeding, and media composition influence cell behavior, and do so in a manner that is dependent 
on the other experimental parameters. As a result, we have developed new insight into the 
mechanisms guiding in vitro tissue formation, which should be applied in future studies in order 
to methodically and rationally design constructs for tissue engineering of bone and cartilage. 
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APPENDIX A 
MEDIA COMPOSITIONS 
Table 3. Medium compositions 
 
Isolation 
Medium 
Proliferation 
Medium 
Chondrogenic  
Medium  
(Chapter 2) 
Chondrogenic  
Medium  
(Chapter 3) 
Osteogenic  
Medium  
(Chapters 2,3,4) 
α-MEMa DMEMb DMEM DMEM DMEM 
10% FBSc 10% FBS 1% ITS+d 1% ITS+ 10% FBS 
1% Anti-Antie 1% Anti-Anti 1% Anti-Anti 1% Anti-Anti 1% Anti-Anti 
10 ng/ml FGF-2f  50 µg/ml ascorbic acid 50 µg/ml ascorbic acid 50 µg/ml ascorbic acid 
  100 nM dexamethasone 100 nM dexamethasone 10 nM dexamethasone 
  50 µg/ml proline 50 µg/ml proline 5 mM β-glycerophosphate 
  10 ng/ml TGF-β3 10 ng/ml TGF-β3  
      10 ng/ml BMP-6   
aalpha-minimal essential media (Invitrogen) 
bDulbecco’s modified essential media (Invitrogen) 
cFetal bovine serum (Invitrogen) 
dInsulin-transferrin-selenium plus (Invitrogen) 
eAnti-biotic and anti-mycotic (Invitrogen) 
fFibroblast growth factor-2 (R&D) 
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APPENDIX B 
PRIMER LIST 
Table 4. qPCR primer sequences and conditions 
 
Gene Forward Primer Reverse Primer Annealing Temp (°C)  
Chapters 
Utilized 
Aggrecan  
(ACAN) 
5'-AGG GGC GAG TGG 
AAT GAT GTT-3' 
5'-GGT GGC TGT GCC 
CTT TTT-3' 56 2, 3 
Alkaline phosphatase 
(ALP) 
5'-GTG CCA GAG AAA 
GAG AAA GAC C-3' 
5'-GTG GAG ACA CCC 
ATC CCA TC-3' 60 3, 4 
Angiopoietin 1  
(ANG1/ANGPT1) 
5'-ACC GAG CCT ATT 
CAC AGT AT-3' 
5'-ACA GTT GTC ATT 
ATC AGC ATC TT-3' 58 3, 4 
Collagen, type I, alpha 1 
(COL1) 
5'-CGA AGA CAT CCC 
ACC AAT CAC-3' 
5'-CAT CGC ACA ACA 
CCT TGC C-3' 60 2, 3, 4 
Collagen, type II, alpha 1 
(COL2) 
5'-GGC AAT AGC AGG 
TTC ACG TAC A-3' 
5'-CGA TAA CAG TCT 
TGC CCC ACT T-3' 52 2, 3 
Cyclophilin A  
(PPIA) 
5'-TTC TGC TGT CTT 
TGG GAC CT-3' 
5'-CAC CGT GTT CTT 
CGA CAT TG-3' 60 2, 3, 4 
Osteocalcin  
(OC/BGLAP) 
5'-ATG AGA GCC CTC 
ACA CTC CTC-3' 
5'-GCC GTA GAA GCG 
CCG ATA GGC-3' 60 3, 4 
Osteonectin 
(ON/SPARC) 
5'-TTG GAG AGT TTG 
AGA ACC TGT G-3' 
5'-TGC AAG GCC CAG 
TGT AGT CC-3' 60 3, 4 
Osteopontin 
(OP/SPP1) 
5'-TGA TGA ATC TGA 
TGA ACT GGT C-3' 
5'-GGT GAT GTC CTC 
GTC TGT AG-3' 60 3, 4 
Runt-related 
transcription factor 2  
(RUNX2) 
5'-CAG ATG GGA CTG 
TGG TTA CTG-3' 
5'-GGT GAA ACT CTT 
GCC TCG TC-3' 56 3, 4 
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APPENDIX C 
ANTIBODY LIST 
Table 5. Primary antibodies used in Chapter 2 
 
1o Antibody Digestion Dilution 2o Antibody 
Collagen type I 
(Abcam, ab292) Pepsin
a 1:200 Goat α Rabbit Alexa Fluor 488 
Collagen type II 
(Millipore, MAB8887) Pepsin 1:100 
Goat α Mouse IgG1 
Alexa Fluor 594 
a0.01% Pepsin in HCl, pH 3.0   
 
 
Table 6. Primary antibodies used in Chapter 3 
 
1o Antibody Digestion Dilution 2o Antibody 
Collagen type I 
(Abcam, ab292) Pepsin
a 1:200 Goat α Rabbit Alexa Fluor 488  
Collagen type II 
(Millipore, 
MAB8887) 
Pepsin 1:100 Goat α Mouse IgG1 Alexa Fluor 594  
Osteonectin 
(DSHB, AON-1 ) - 1:20 
Goat α Mouse IgG1 
Alexa Fluor 594  
Osteocalcin 
(Abcam, ab13420) - 1:100 
Goat α Mouse IgG3 
Alexa Fluor 594  
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Table 7. Primary antibodies used in Chapter 4 
 
1o Antibody Digestion Dilution 2o Antibody 
Collagen type I 
(Abcam, ab292) Pepsin
a 1:200 Goat α Rabbit Alexa Fluor 488  
Osteonectin 
(DSHB, AON-1 ) - 1:20 
Goat α Mouse IgG1 Alexa 
Fluor 594  
Osteocalcin 
(Abcam, ab13420) - 1:100 
Goat α Mouse IgG3 Alexa 
Fluor 488 
Osteopontin 
(MPIIIB10(1)) - 1:20 
Goat α Mouse IgG1 Alexa 
Fluor 594  
 
 
 
Table 8. Secondary antibodies 
 
2o Antibody Species Dilution 
Alexa Fluor 488  
(Invitrogen, A-11008) 
  
Goat α Rabbit 1:500 
Alexa Fluor 594  
(Invitrogen, A-21125) 
  
Goat α Mouse 
IgG1 
1:1000 
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APPENDIX D 
COMPARISON BETWEEN MSC CHONDROGENESIS WITH AND WITHOUT BMP-6 
 
Figure 25. DNA content of cultures in chondrogenic medium with and without BMP-6  
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 Figure 26. GAG and collagen content of cultures in chondrogenic media with 
and without BMP-6 
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